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Sleep disturbance is recognized in the literature as a highly prevalent feature of 
Rare Genetic Neurodevelopmental Disorders (RGND) in children. Despite the 
considerable number of studies that have reported the presence of sleep difficulties 
within this cohort, limited attention has been paid to the treatment of these sleep 
problems, and even less so investigating the effectiveness of FBA-based 
behavioural interventions, and the outcomes of such treatment methods on general 
child behaviour and parental wellbeing. The purpose of this study was to determine 
whether FBA-based behavioural sleep interventions are effective with children with 
RGND, to examine the impact that intervention may have on secondary outcome 
variables pertaining to general child behaviour and parental wellbeing, sleep, and 
relationship satisfaction, and to ultimately establish the acceptability of this form of 
treatment amongst parents. Three children aged between six and 12 took part in the 
study. The study followed a multiple-baseline-within-participants design and included 
measures taken at pre- and post-intervention time-points. The FBA-based 
behavioural interventions were found to be effective in the treatment of the children’s 
sleep difficulties overall, with improvements observed across sleep onset latency, 
night wakings, and co-sleeping. General child behaviour, as measured by the VABS-
II and the CBCL at pre- and post-treatment, had variable patterns of change across 
participants and across specific variables. Similarly, parental wellbeing, sleep, and 
relationship satisfaction, as measured at pre- and post-treatment by the DASS-21, 
PSQI, and the RQI, were mixed in their results. Despite the variability seen in these 
findings, the parents of all three children rated their acceptability of treatment highly 
on the TARF-R, and their post-treatment interviews reiterated their satisfaction with 
their child’s intervention, most aspects of the study process, and the secondary 
outcomes that they noticed. The present findings contribute to the limited existing 
literature concerning the utilization of FBA-based behavioural sleep intervention with 
children with RGND, and the secondary effects of treatment on general child 
behaviour and parental wellbeing following such interventions. However, future 
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research should endevour to address and rectify the limitations encountered in the 











Rare Genetic Neurodevelopmental Disorders and Sleep 
 
 
Sleep disturbance is recognized in the literature as a highly prevalent feature of 
Rare Genetic Neurodevelopmental Disorders (RGND) in children. A number of 
studies have reported the presence of sleep difficulties within this cohort, with 
between 30 to 90% of children with Angelman syndrome, Prader-Willi syndrome, 
Fragile X, Rett syndrome, and Williams syndrome experiencing some form of sleep 
disturbance (Annaz et al., 2011; Kronk et al., 2010; Richdale et al.,1999; Summers et 
al., 1995). Insomnias, including difficulties with sleep onset latency, night wakings 
and early morning wakings appear to be relatively consistent manifestations of sleep 
disturbance across the aforementioned syndromes (Annaz et al., 2011; Bruni et al., 
2004; Cassidy et al., 1990; Kronk et al., 2010), however presentations do vary 
considerably and some sleep problems (e.g., excessive daytime sleepiness) occur 
more frequently among those with specific disorders (Hoban, 2000).  
 
Behavioural interventions including antecedent-based and consequence-based 
procedures such as sleep hygiene and modification of bedtime routines, faded 
bedtime schedules, and extinction have considerable empirical support in the 
treatment of sleep problems among typically developing children (Johnson & Mindell, 
2011; Owens, Palermo, & Rosen, 2002) and children with autism spectrum disorder 
(Turner & Johnson, 2012; Vriend et al., 2011). However, treatment studies 
investigating the effectiveness of these approaches with children with RGND are 
scarce. Research wherein behavioural strategies have been used, report positive 
treatment effects and henceforth provide strong support for further research in this 
area. 
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The current study will extend the current corpus of literature by assessing the 
effectiveness of FBA-based, behaviourally-based interventions for sleep problems in 
children with RGND.  
 
In this chapter, a description of RGND is provided, along with the other 
challenging behaviours that are typically present in these disorders. The prevalence, 
type, and cause of sleep problems in children with RGND are also detailed in this 
section. Finally, the chapter concludes with a summary of the interventions 
frequently used in the treatment of sleep disturbance, and the functional behaviour 
assessment (FBA) framework that can be used to guide the selection of such 
interventions. Where appropriate, for the purpose of brevity, particular attention will 
be paid to Fragile X syndrome and Prader-Willi syndrome, as these are the 
diagnoses of two of the three children that took part in the present study. The third 
child presented with a unique chromosomal abnormality that is not associated with 
any labeled RGND. 
 
 
Rare Genetic Neurodevelopmental Disorders 
 
Definition. Genetic disorders are caused by “dysfunctional gene behaviour” or a 
mutation in the genome (World Health Organization, 2019). The structure and 
number of gene abnormalities determines the phenotype or observable 
characteristics of a disorder. Abnormalities may be typified by a single gene 
mutation, or may involve the addition or deletion of whole chromosomes (World 
Health Organization, 2019). Given the great multitude of possible abnormalities, 
there is suitably a multitude of genetic disorders. Rare genetic neurodevelopmental 
disorders (RGND) are a group of conditions that fall within this categorization, 
resulting from some form of genetic mutation which in turn disrupts typical human 
growth and development, particularly as it pertains to the nervous system 
	 17	
(Kindsvatter & Geroski, 2014). These conditions usually have an early onset, and as 
such the characteristics of these disabilities begin to become apparent during 
childhood and tend to persist (American Psychiatric Association, 2013). The 
European Union recognizes a disorder as being rare if it affects less than 5 in 10,000 
of the general population (European Commission, 2008), and these syndromes have 
been determined as “rare” by the National Organization for Rare Disorders 
(EUROCAT, 2012). While there are no formal statistics to represent the prevalence 
of RGND as a group, it is known that 1-2% of the general population are diagnosed 
with neurodevelopmental disorders (Grigg-Damberger & Ralls, 2013), suggesting an 
even lower occurrence for those deemed “rare”. The various genetic mutations of 
RGNDs are expressed phenotypically in the form of physiological, intellectual, and 
developmental impairments (Davis et al., 2018). Additionally, the acquisition of 
motor, social, language, and cognitive skills is typically inhibited to varying extents 
due to abnormal brain function (Jeste, 2015).  While physical and behavioural 
presentation can differ markedly depending on the individual chromosomal profile, 
each syndrome does include certain traits that are recognized as being characteristic 
of their RGND.    
 
Syndromes diagnosed in study participants.  
Fragile X syndrome. Fragile X syndrome (FXS) is caused by a mutation on the 
FMR-1 gene on the X chromosome, (Wheeler et al., 2015) resulting in a reduction in 
FMR1 protein (FMRP) levels (del Hoyo Soriano et al., 2018). Given that the X 
chromosome is implicated in this condition, females are not as frequently affected as 
males, and in the cases in which females are diagnosed, the symptoms are often 
more mild (del Hoyo Soriano et al., 2018). It has been found that between 1 in 3717 
and 1 in 8918 people of European descent have Fragile X syndrome (Crawford et 
al., 2001). Physical features that typically present in individuals with Fragile X 
syndrome include an elongated face, prominent jaw, large ears, macroorchidism, 
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macrocephaly, flat feet, a narrow and highly-arched palate, and hyperextensible 
joints (Kidd et al., 2014; Schwarte, 2008).  
People with Fragile X syndrome often present with a mild to severe intellectual 
disability (Bailey, Raspa, Olmsted, & Holiday, 2008; Roberts, Mirrett, P., & Burchinal, 
2001; Roberts, McCary, Shinkareva, & Bailey, 2016), executive functioning, 
attention, and visual-spatial recognition difficulties, hyperactivity, and impulsivity, and 
seizure disorders (Kidd et al., 2014; Sullivan et al., 2007; Wheeler et al., 2015). 
There are also some overlapping features that are shared between FXS and autism 
spectrum disorder (ASD), such as difficulties with language and communication, 
poor eye contact, abnormal responses to sensory stimuli, and stereotypic behaviours 
(Kaufman et al., 2004; Kidd et al., 2014; Klusek, Martin, & Losh, 2014a). Accordingly, 
approximately 60% of males and 30% of females that receive a diagnosis for FXS 
also meet criteria for ASD (Garcia-Nonell et al., 2008; Klusek, Martin, & Losh, 
2014a).  
 
Prader-Willi syndrome. Prader-Willi syndrome (PWS) is a neurodevelopmental 
disorder that is caused by the non-functioning or absence of the paternally inherited 
genes at 15q11.2-q13 (OMIN #176270) (Goldstone et al., 2008). People with PWS 
often present with a mild to moderate intellectual disability, behavioural 
abnormalities, and a distinctive physical phenotype (Tunnicliffe, Woodcock, Bull, 
Oliver, & Penhallow, 2014). The physical characteristics typically found in individuals 
with PWS are almond-shaped eyes, narrow forehead and face, small triangular 
mouth, thin upper lip, underdeveloped genitalia, small stature, small hands and feet, 
and tapered fingers (Cassidy, Schwartz, Miller, & Driscoll, 2012; Goldstone et al., 
2008; Kundert, 2008; Tunnicliffe et al., 2014). Hypopigmentation may also be found 
in individuals whose PWS and is caused by deletion of 15q11.2-q13 on the 
paternally derived chromosome (Goldstone et al., 2008). PWS has an estimated 
incidence of 1 in 10,000 to 1 in 25,000 live births (Khavat et al., 2017).  
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While the phenotypical presentation of Prader-Willi syndrome changes over the 
course of development (Boer & Clarke, 1999; Dosier, Vaughn, & Fan, 2017), it is 
characterised by low muscle tone (a condition known as hypotonia), deficiency in the 
production of sex hormones by the sex glands, affecting growth and sexual 
development (known as hypogonadism or cryptorchidism), general developmental 
delay (Beauloye et al., 2015; Holland et al., 1993; 1995; Khayat et al., 2017; Kundert, 
2008; Pavone et al., 2015), mild to moderate cognitive impairment, autistic 
characteristics, and aggression (Dosier, Vaughn, & Fan, 2017), hyperphagia 
(overeating) and consequently result in a number of health comorbidities including 
obesity, hypothyroidism, Type 2 diabetes, and respiratory issues (Laurier et al., 
2015). Additional features that emerge include the inefficient secretion of growth 
hormones, adrenotonsillar hypertrophy, and sleep disordered breathing (Beauloye et 
al., 2015). These clinical conditions have been attributed to hypothalamic-pituitary 
dysfunction (Beauloye et al., 2015). Symptoms that are more psychological in nature 
tend to emerge in adolescence, particularly symptoms of depression and anxiety, 
particularly low energy, lethargy, withdrawal, confusion, temper tantrums and 
obsessive-compulsive behaviours (Goldstone et al., 2008; Kundert, 2008; Pavone et 
al., 2015).  
 
Challenging Behaviours in People with Rare Genetic Neurodevelopment Disorders 
Children with rare genetic neurodevelopmental disorders (RGND) are 
commonly reported to exhibit a number of challenging behaviours that negatively 
impact their own functioning and wellbeing, as well as that of their family members 
(Hodap & Dykens, 2007; Holm et al., 1993; Neo & Tonnsen, 2019; Reilly et al., 2015; 
Waite et al., 2017).  
There are a number of concerning behaviours that are syndrome-specific, 
wherein they may be a distinctive feature of that particular genetic mutation. An 
example of such a syndrome-specific behavior is insatiable appetite and overeating 
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(“hyperphagia”), as is seen in Prader-Willi syndrome (Boer & Clarke, 1999; Cassidy 
et al., 2012; Kundert, 2008; Tunnicliffe et al., 2014). In this case, the challenging 
behavior in question may be attributed to dysfunction of the hypothalamus, a brain 
region that is recognized as being impaired in PWS (Beauloye et al., 2015). Other 
challenging behaviour typically featured in those with PWS include compulsive 
behaviours and temper tantrums (Dimitropoulos et al., 2006; Maas et al., 2010; 
Tunnicliffe et al. 2014). Angelman syndrome is similarly associated with a selection 
of distinct challenging behaviours including hyperactivity, and aggression, often in 
the form of property destruction (Didden et al., 2009; Strachan et al, 2009; Zhdanova 
et al., 1999). For children with Williams Syndrome, anxious and depressive 
symptomology is commonly exhibited (Leyfer et al., 2006). Unfortunately, prevalence 
statistics have not been reported in the literature as of yet for these syndrome-
specific challenging behaviours and thus future research will be needed to establish 
such incidence rates. 
Additionally, some problematic behaviours are a shared clinical feature 
occurring across RGND (e.g., self-injury; Hall, Arron, Sloneem, & Oliver, 2008). 
Sleep is another area of challenging behaviour for many children with RGND.  
 
Sleep in children with Rare Genetic Neurodevelopmental Disorders 
The function of sleep. Although the exact function of sleep has not yet been 
established, it has been determined that it plays a critical role in human 
development, as evidenced by the fact that children spend more time sleeping than 
any other activity (Wiggs, 2007). In addition to this anecdotal inference, the 
association between sleep and developmental processes such as physical growth, 
brain growth, memory consolidation, energy conservation, behavioral and emotional 
regulation, learning and attention, and social interaction is well recognised (Brown, 
Kuo, Phillips, Berry, & Tan, 2013; Deliens et al., 2015; Richdale, 2013; Staples, 
2013; Stores & Wiggs, 1998; Turner & Johnson, 2012). Researchers and health 
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professionals in the field of child development heed the numerous health 
ramifications of poor sleep (Fallone, Owens & Deane, 2002). Cardiovascular, 
metabolic, and autoimmune disorders are among some of the physical health 
conditions with which poor sleep has been found to be associated (Brown et al., 
2013; Colten et al., 2006; McDougall, Kerr, & Espie, 2005). Sleep deprivation has 
also been linked to increases in stress responsivity, somatic pain, increased 
incidence of mood disorders, impairments related to memory, cognition, and 
performance, poor psychosocial health, academic difficulties, increase in risk taking 
behaviours including drunk driving, smoking, and delinquency, decreased quality of 
life, and behavioural problems (Ahrberg, Dresler, Niedermaier, Steiger, & Genzel, 
2012; Bagley & El-Sheikh, 2013; Lushington et al., 2013; Medic, Wille, & Hemels, 
2017; Owens, 2014; Reale, Guarnera, & Mazzone, 2013; Schmidt & Van der Linden, 
2015). Thus the significant impact that sleep problems can have on children with 
RGND and the wider family ecology provides ample justification for the investigation 
into effective intervention approaches.  
 
Categories of sleep disturbance. There are three main classifications for sleep 
disorders in children, adolescents, and adults, either typically developing or 
otherwise. These are: (1) dyssomnias, (2) parasomnias, and (3) sleep disorders 
which are diagnostic features of an illness or disorder (e.g., sleep apnoea/sleep-
disordered breathing) (American Academy of Sleep Medicine, 2014; American 
Psychiatric Association, 2013; Krakowiak, Goodlin-Jones, Hertz-Picciotto, Croen, & 
Hansen, 2008). 
  
Dyssomnias. Dyssomnia is a term which comprises insomnia and 
hypersomnia, those being difficulty initiating or maintaining sleep, and excessive 
sleepiness, respectively (American Academy of Sleep Medicine, 2005; Esbensen & 
Schwichtenberg, 2017). Insomnias may be further divided into two categories: 
behavioural insomnias, where presentations may include irregular sleep-wake 
patterns, night-time wakings, early morning waking, settling difficulties, delayed sleep 
	 22	
onset latency, and bedtime resistance (Esbensen & Schwichtenberg, 2017; Nunes & 
Bruni, 2015; Spruyt & Curfs, 2015), and insomnias caused by physiological factors, 
such as pain, abnormal melatonin levels, heart problems, and acid reflux (Esbensen 
& Schwichtenberg, 2017). An alternative conceptualization of dyssomnias organizes 
the sleep difficulties into intrinsic (the cause being from within the body), extrinsic 
(cause relating to pathological environment or conditions), and circadian rhythm 
disorders (Thorpy, 2012).  
 
Parasomnias. Parasomnias are atypical arousals that take place during sleep 
and include sleep walking, sleep talking, excessive nightmares, and sleep terrors 
(Esbensen & Schwichtenberg, 2017; Markov, Jaffe, & Doghramji, 2006; Thorpy, 
2012). These sleep-events involve behaviours, movements, perceptions, emotions, 
and autonomic nervous system functioning (Thorpy, 2012). Parasomnias are 
commonly distinguished as arousal disorders, sleep-wake transition disorders, 
parasomnias of Rapid Eye Movement (REM) sleep, and nonspecific parasomnias 
(Davis, Parker, & Montgomery, 2004; Thorpy, 2012). 
 
Sleep apnoea/sleep-disordered breathing. Sleep-disordered breathing is an 
umbrella term encompassing such conditions as Obstructive Sleep Apnoea (OSA), 
Central Sleep Apnoea (CSA), and hypopnea (Murata et al., 2017). Sleep apnoea 
refers to the temporary lapse in breathing or shallow breathing that can occur during 
sleep in these conditions. In this way, sleep disordered breathing is considered a 
dyssomnia, due to its disruption to sleep. Although the focus of this thesis is on 
remedy of behavioural sleep problems, it is important to consider the exacerbating 
effect of such conditions on sleep disturbance in typically developing children, as 
well as children with RGND (Camfferman et al., 2006; Hamlin et al., 2011; Pavonne 
et al., 2015; Verbraecken et al., 2002). 
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Prevalence of sleep problems in RGND.  Sleep difficulties are a commonly 
reported clinical problem among the parents of children with RGND.  Contrasted with 
typically-developing preschool-aged children, of whom approximately 25% are 
reported by their parents to experience sleep problems, children with 
neurodevelopmental disorders have a significantly higher prevalence of sleep 
disturbance of some form (Blackmer & Feinstein, 2016; Robinson-Shelton & Malow, 
2016). Studies indicate that between 30% to 90% of children with RGND present 
with some type of sleep disturbance (Annaz et al., 2011; Dykens & Kasari, 1997; 
Kidd et al., 2014; Kronk et al., 2010; Richdale, Cotton, & Hibbit, 1999; Summers, 
Allison, Lynch, & Sandley, 1995; Wong, Leonard, Jacoby, Ellaway & Downs, 2015; 
Young, Nagarajan, de Klerk, Jacoby, Ellaway, & Leonard, 2007). This compares to 
just 10 to 35 percent of typically developing children (Armstrong, Quinn, & Dadds, 
1994; Bryars, Yolton, Rausch, Lanphear, & Beebe, 2012; Courturier et al., 2005; 
Davis et al., 2004; Gaylor, Goodlin-Jones, & Anders, 2001; Krakowiak et al., 2008; 
Lam, Hiscock, & Wake, 2003; Owens & Moore, 2017; Richdale & Schreck, 2009a; 
Scher et al., 1995; Singh & Zimmerman, 2015; Wake et al., 2006). The wide range in 
prevalence estimates reported in the literature may be attributed in part to such 
factors as variability in study aims and design, the type of neurodevelopmental 
disorder examined, and the type of sleep problems studied (Didden et al., 2002; Elia 
et al., 2000; Honomichl et al., 2002; Walz, Beebe, & Briars, 2005). In addition, 
estimates of sleep disturbance experienced by children may be skewed if those 
difficulties are not disruptive to the rest of the family or disregarded as “normal”, and 
therefore go unreported. Lack of parental understanding with regard to the 
appropriateness of certain sleep-related behaviours at different developmental 
stages may cause over-reporting, and henceforth overestimated prevalence 
statistics (Kronk et al., 2010). 
 
Course of sleep problems in RGND. Sleep disturbance can persist in this 
population into adolescence and adulthood, especially if left untreated (Grigg-
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Damberger & Ralls, 2013; Ipsiroglu et al., 2011). Sleep problems in typically 
developing children on the other hand have been shown to decline with age (e.g., 
72% to 37% from age 2-5 to 10-17 years old) (Allik, Larsson, & Smedje, 2008; 
Clarkson, Williams, & Silva, 1986; Fisher, Pauley, & McGuire, 1989; Gregory & 
O’Connor, 2002; Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014; Richdale & 
Prior, 1995; Sivertsen, Posserud, Gillberg, Lundervold, & Hysing, 2012). Such 
sustained sleep difficulties are likely to negatively impact learning, behaviour, and 
cognitive develop in both the short- and long-term (Colten & Altevogt, 2006; Kronk, 
Bishop Raspa, Bickel, Mandel, & Bailey, 2010; Wiggs & Stores, 1996). Furthermore, 
child sleep problems may have a concurrently negative impact on the well-being, 
quality of life, physical and mental health of the broader family system (Chu & 
Richdale, 2009; Cotton & Richdale, 2010; McDougall et al., 2005). In a qualitative 
investigation of the experience of parents of children with Rett syndrome (RTT), 
McDougall et al., (2005) found mood, energy levels, and performance to be 
compromised as a result of their child’s sleep problems. Similarly, the researchers 
uncovered a theme across participants that was characterized by strained relations 
between parents and general social nonfulfillment (McDougall et al., 2005). 
 
Causes of sleep problems in children with RGND. In order to determine which 
are the most appropriate interventions, it is advantageous to first understand the 
etiology of the sleep problem. Within normally-developing populations, sleep 
disturbance is often rooted in behavioural causes (Owens & Mindell, 2011), however 
the etiological basis of sleep problems in children with RGND is multifactorial, 
consisting of biological (including comorbid health conditions), environmental, 
psychological, behavioural, and social factors (Robinson-Shelton & Malow, 2016). 
Also, given the unique nature of each RGND, research has uncovered 
heterogeneous, syndrome-specific variables contributing to the development and 
maintenance of sleep problems present in children with RGND (Blackmer & 
Feinstein, 2016; Clayton-Smith, 1993; Dan & Boyd, 2003; Didden, Korzilius, Smits, 
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Curfs, & Dykens, 2004; Goldman, Bichell, et al., 2012; Miano et al., 2004; Miano et 
al., 2008). 
 
Biological factors. The literature that explores the cause of sleep problems in 
children with RGND is dominated by investigation into biological abnormalities, for 
example, circadian rhythm disturbances, abnormalities in sleep architecture or 
sleep/wake schedules, issues with the production and synthesis of melatonin, 
comorbid health conditions such as seizure disorders and conditions that impair 
one’s ability to breathe, such as Central Sleep Apnoea (CSA), Obstructive Sleep 
Apnea (OSA), and hypopnea (Lin et al., 2007; Murata et al., 2017; Pavone et al., 
2015; Urquhart et al., 2013), and side effects of medication (Braam et al., 2008; 
Forrest et al., 2009; Hiroe, 2000; Kronk et al., 2010; Dosier et al., 2017; Potocki et 
al., 2000; Spryt, Braam, Smits, & Curfs, 2016; Takaesu et al., 2012).  
 
Sleep and wake states in humans are controlled by their internal circadian 
rhythm, which is in turn regulated by the neurohormone melatonin (Arendt, 2005; 
Didden & Sigafoos, 2001). The typical course of sleep/wake schedule development 
begins with the polyphasic sleep pattern (meaning sleep for multiple periods 
throughout the day) exemplified in newborns, then transitions to a biphasic pattern 
(i.e., sleeping for two periods over the course of a day) at approximately three 
months of age in typically-developing infants, and then eventually evolves into a 
monophasic pattern (i.e., a singular sleep period each day) by three to four years 
(Ferber, 1996; Richdale, 1999). While sleep problems arising from such sleep 
patterns may be ‘disruptive’ in a child’s early years, they are developmentally 
appropriate. On the other hand, a sleep/wake schedule would be considered 
‘disordered’ if the presenting sleep problems were rooted in some abnormality in the 
physiology of that sleep/wake schedule (Ferber, 1996; Richdale, 1999). For instance, 
abnormally low levels of melatonin and abnormal regulation of basic circadian 
rhythms have been identified as having a causal role in disordered sleep/wake 
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schedules amongst children with higher prevalence developmental disorders, such 
as ASD (Melke et al., 2008; Tordjman et al., 2013), as well as with children with 
some RGNDs (Dosier, Vaughn, & Fan, 2017; Miyamoto et al., 1999; Takaesu, 
Komada, & Inoue, 2012). 
 
The sleep difficulties and their hypothesized physiological underpinnings of the 
syndromes of participants included in this study are described below. 
 
Sleep and Fragile X Syndrome. There is limited research analyzing sleep 
problems within samples of children with FXS, and even fewer examine FXS when it 
is not accompanied with a comorbid diagnosis of ASD or other conditions, however 
the existing research has shown that difficulties settling, increased wake-time after 
sleep onset, and shorter overall sleep duration are experienced by children with FXS 
(Gould et al., 2000; Miano et al., 2008; Richdale, 2003). An estimated 31-77% of 
individuals with FXS present with some form of sleep disturbance (Kronk et al., 2010; 
Richdale, 2003). The types of sleep problems exhibited in cases with FXS are akin to 
those experienced by the typically developing population (Harvey & Kennedy, 2002). 
In spite of the apparent similarities in sleep disturbance type across the two cohorts, 
research has found that individuals with FXS display sleep microstructure 
abnormalities, demonstrated specifically by lower transient slow EEG oscillations 
during non-REM sleep (Miano et al., 2008). In addition, the sleep architecture of 
children and young adults with FXS appears to comprise a high percentage of stage 
1 sleep, and a low percentage of REM sleep, as well as having a low number of 
REM episodes compared to that of typically developing children (Miano et al., 2008).  
 
Sleep and Prader-Willi Syndrome. Insomnia (i.e., difficulty settling, sleep onset 
delay, sleep maintenance), early morning waking, and excessive daytime sleepiness 
are typical sleep problems associated with PWS (Cassidy, McKillop, & Morgan, 
1990; Cotton & Richdale, 2006; Gibbs, Wiltshire, & Elder, 2013; Richdale, Cotton, & 
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Hibbit, 1999). Prevalence of the above sleep difficulties range from 35 to 100% 
amongst children with PWS (Richdale, Cotton, & Hibbit, 1999; Tietze et al., 2012). 
Actigraphy, which is an objective measure of motor movement and provide a picture 
of sleep/wake patterns (Sadeh, 2011), and PSG studies have demonstrated that 
children with PWS have longer wake after sleep onset time, while at the same time 
having shorter sleep latency (Gibbs et al., 2013; Joo et al., 2010; Verillo et al., 2009; 
Vgontzas et al., 1996). Compared to typically developing children, those with PWS 
have longer wakeful periods and display more daytime sleepiness, however the two 
populations are similar with regard to total sleep time and frequency of night waking 
(Gibbs et al., 2013). Manni et al (2001) observed abnormal REM sleep patterns in 
people with PWS, specifically an earlier REM sleep onset compared to typically 
developing individuals.  
 
Sleep-disordered breathing is often present in children with Prader-Willi 
syndrome, given the dysmorphism to the face, small nasopharynx, and small 
oropharynx with or without adenotonsillar hypertrophy (Pavone et al., 2015). CSA 
has been found to be prevalent in individuals with PWS, an observation that some 
have suggested may be due to their lower resting functional residual capacity (FRC) 
resulting from hypotonia and decreased respiratory muscle strength found in infants 
with PWS (Urquhart et al., 2013). This increases their risk for sleep-related 
hypoventilation, especially when in REM sleep. An additional contributing factor to 
such impairment in central respiratory control experienced by children with PWS, 
may be related to hypothalamic dysfunction and blunted chemoreceptor sensitivity 
following hypoxemia and hypercapnia which is common in such children (Pavone et 
al., 2015; Urquhart et al., 2013). Individuals with PWS are also frequently diagnosed 
with Obstructive Sleep Apnoea (OSA), purportedly linked to the increased incidence 
of obesity within this population (Lin et al., 2007; O’Donoghue et al., 2005).  
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Despite the evident physiologically-based differences in the sleep of children 
with RGND compared to the sleep of typically-developing children, there may also be 
a behavioural component to their sleep difficulties. The demonstrable role that 
environmental and learning factors have been shown to play in the sleep disturbance 
of children with higher prevalence developmental disorders (i.e., ASD, ADHD; 
Devnani & Hegde, 2015; Meltzer & Mindell, 2008; Reynolds & Malow, 2011; Sharma 
& Andrade, 2012) raises the question of whether such variables may be similarly 





Behavioural model of sleep disturbance. A behavioural model of sleep 
disturbance has its basis in operant behavior theory (Didden et al., 2002). Operant 
behavior theory holds that the probability of a behaviour recurring under similar 
conditions is dependent on the antecedents (A) to the behavior/response (B), 
coupled with the consequences (C) that follow said behavior (Skinner, 1969). 
Specifically, the likelihood of behavioural repetition hinges on the nature of the 
contingencies and their interrelationship with the antecedents and the 
behavior/response itself. Antecedents are defined as discriminative stimuli that result 
in the occurrence of the behavior/response (Blampied, 2013). Consequences or 
contingencies are categorized as either reinforcers or punishers, respectively 
increasing or decreasing the likelihood of the behavior/response transpiring again 
(Blampied, 2013). Further, a reinforcing or punishing consequence may be deemed 
positive meaning that the contingency involves something being added into the 
situation or environment, or negative meaning that the contingency takes the form of 
something being removed from the situation or environment (Skinner, 1969).  
 
While the behavioural model may be applied to sleep, it is important to note 
that sleep is not technically classified as a behaviour (Blampied & France, 1993; 
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Blampied, 2013). Sleep is instead deemed a biological state that does not appear to 
reliably fulfill the criteria of an operant behaviour, in particular, that the likelihood of 
its recurrence may be manipulated through its consequences (Blampied & France, 
1993). It is held instead that the act of “falling asleep” may be better suited to serve 
as the instrumental behaviour in this model, as it is clearly under the control of 
discriminative stimuli, and is consequently reinforced by sleep itself (Blampied & 
France, 1993).  
 
Of course, the behaviour of “falling asleep” does not occur in isolation, that is to 
say that there is typically a sequence of behaviours that lead to the ultimate act of 
falling asleep, and then sleep itself. In the consideration of behaviours that take 
place consecutively, the notion of ‘operant behavior chains’ come into play. Within 
such a chain, antecedents and consequences have dual-functionality, each acting to 
reinforce the behaviour that came before while simultaneously performing the role of 
discriminative stimuli, signaling for the next behaviour to occur. The discriminative 
stimuli present before and after each behaviour in the chain will either cause 
momentum toward the desired state (i.e., sleep), or disrupt the momentum (Skinner, 
1969).  
 
Discriminative stimuli in the context of sleep fall into three categories: 
interoceptive stimuli (e.g., fatigue, which relies on the quality and duration of recent 
sleep combined with the length of time since last waking), proprioceptive stimuli 
(e.g., from posture and body orientation), and exteroceptive stimuli (i.e., elicited from 
the physical environment and social context in which the wake-sleep transition takes 
place). Time of day at which an attempt at sleep initiation is to occur is another 
critical discriminative stimulus, and may be considered both an interceptive and 
external stimulus (Blampied & France, 1993; Blampied, 2013). It is said that the 
sleep initiation process is under stimulus control once an assortment of distinctive 
stimuli become associated consistently with the behaviour of “falling asleep” and are 
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consistently reinforced by sleep (Blampied, 2013). It follows then that when in pursuit 
of the desired behavioural outcome of falling asleep, the discriminative stimuli of the 
entire behaviour chain that prelude it must be consistently present to ensure its 
attainment, otherwise unintended reinforcers such as choice, disruption, or 
distraction may impede progression toward falling asleep (Blampied, 2013; Blampied 
& France, 1993). Bed refusal and sleep onset delay are possible consequences of 
inconsistent and/or indistinct exteroceptive cues involved in the behaviour chain 
concerning pre-sleep bedtime routines and falling asleep (Blampied & France, 1993). 
The risk of obstructed momentum toward sleep is especially high when sleep-
competing discriminative stimuli are conspicuous in the environment or when the 
reinforcement that they offer is attractive and immediate (Blampied, 2013).  
 
In order to maximize the likelihood of sleep initiation, having in place sleep-
conducive antecedent stimuli during a bedtime routine is necessary (Blampied & 
France, 1993). Quiet, darkness, cool room temperature, and comfortable bedding 
are discriminative stimuli in the sleep environment that encourage a period of 
“behavioural quietude,” which is a state characterised by “the reduction of overt 
motor activity, covert cognitive activity, and the lowering of perceptual stimulation,” 
that ultimately results in falling asleep (Blampied, 2013; Blampied & France, 1993; 
Jin et al., 2013; Blampied, 2013, p. 174). Behavioural quietude is necessary in order 
for sleep-controlling internal cues to become salient and henceforth noticed, and that 
continued activity or stimulation may stifle the recognition of such (Blampied & 
France, 1993).  
 
 Co-sleeping, being placed into bed after falling asleep elsewhere, being fed, 
rocked, sung to, patted, walked, or driven around are steps that parents commonly 
believe are required in order for their child to sleep and they will willingly 
enable/enact for such purposes (Blampied, 2013; Blampied & France, 1993; Jan et 
al., 2008). While these rituals may aid in sleep initiation, they depend on the 
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participation of others (i.e., a parent/caregiver). The longer these patterns of 
inappropriate, parent-supplied discriminative stimuli are in place, the stronger their 
association with falling asleep becomes, such that even a slight deviation from the 
established pattern will hinder sleep onset (Blampied, 2013) or sleep reinitiation 
following night wakings (Blampied & France, 1993). For example, in the case of co-
sleeping, the presence of the parent may become associated with sleep initiation 
and thus becomes a discriminative stimulus that is required for the child to fall asleep 
or re-initiate sleep after a night-time waking (France & Henderson, 1996).  
 
Adding to the issue is the fact that parental attention brings with it comfort, 
engagement, and warmth, which can be a powerful and alluring reinforcer for 
children, given the immediacy of its effect (Blampied & France, 1993). Attention from 
a parent is oftentimes more enticing than sleep itself, meaning that it will likely 
compete with the biological state to become the dominant reinforcer (Blampied & 
France, 1993). When a child learns that such problem behaviour as bedtime refusal 
and expressions of distress will result in their parent attending to them, the behaviour 
is strengthened and the likelihood of its recurrence increased (Blampied, 2013). 
Further, double reinforcement occurs when an expression of distress is successful in 
gaining parental attention, where the behaviour is negatively reinforced by the 
escape it provides from the unpleasantness of solitude, while simultaneously being 
positively reinforced by the attention (Blampied & France, 1993). Then, with the 
provision of comfort and attention in response to their child’s distress, parents 
experience relief from their child’s aversive/disruptive behaviour, and they 
themselves are negatively reinforced. This mutually reinforcing interaction, creates a 
coercive behaviour trap, wherein both the child’s and parent’s behaviour are 
strengthened, and the likelihood of their future engagement in the same attention-
seeking and attention-giving behaviours is increased (Blampied, 2013).  Following 
the ongoing recurrence of this interaction, both the child and the parent refine their 
roles in order to avoid distress, through the increasingly earlier instigation of 
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engagement or attention on the part of the child, and the increasingly rapid response 
to their child, on the part of the parent (Blampied & France, 1993).  Each party gets 
something out of the transaction that is beneficial in the short-term, but ultimately 
aversive in the long-term. As with any persistent discriminative stimuli, a coercive 
behaviour trap that is played out consistently will eventuate in the child requiring it in 
order to fall asleep (Blampied, 2013). What may have initially been a 
developmentally and socially acceptable set of discriminative stimuli, later produces 
bedtime tantrums, sleep-onset delay, and bed refusal (Blampied & France, 1993), 
and importantly highlights an inability to self-soothe and initiate sleep independently.  
 
Alternatively, and more appropriately, positive sleep practices may be 
established wherein the child is able to fall asleep without parental presence and 
stimulation or activity. Then discriminative stimuli that are associated with the sleep 
environment or routines (e.g., soft toys, bedding, thumb sucking in younger children 
– or postural adjustments, relaxing, and turning away from sources of stimulation in 
older individuals), as opposed to discriminative stimuli associated with parental 
attention or reliance on other parent-supplied cues (Blampied & France, 1993; 
Blampied, 2013), can lead the child into the state of sleep initiation. These more 
appropriate discriminative stimuli are then reinforced by the sleep that follows. Bed-
associated cues or self-produced comfort cues for sleep also help to encourage 
sleep re-initiation in children if they wake in the night, as the same stimuli that 
signaled for them to fall asleep at bedtime are present still in the child’s immediate 
surroundings (Blampied & France, 1993; Blampied, 2013). Such self-soothing 
methods and objects will then be reinforced by the sleep that follows (Blampied & 
France, 1993; Blampied, 2013; Henderson et al., 2010). Ideally, reinforcement will 
follow sleep compatible behaviours comprising the behaviour chain, serving to 
strengthen and maintain them, and not behaviour that is incompatible with positive, 
self-regulated and self-initiated sleep.  
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Ultimately, given the multitude of different factors described above, it appears 
that sleep disturbance in children with RGND is the byproduct of an interaction 
between biological/physiological, behavioural, and environmental factors. The 
degree to which each of these factors is responsible for sleep problems is variable 
across each individual child, and thus cannot be assumed. Henceforth, each factor 
must be given consideration in the formulation of sleep interventions.  
 
Common Interventions for Sleep Disorders 
A variety of treatments have been developed to improve sleep (Richdale & 
Wiggs, 2005). The most common, empirically supported treatment approaches are 
pharmacological or behavioural (Braam et al., 2008; Malow et al., 2012; Mindell et 
al., 2006; Turner & Johnson, 2013; Vriend et al., 2011). 
 
Pharmacological interventions. Medications are used frequently in the 
treatment of sleep problems in children. This is in part, due to the fact that they 
provide an effective and often expedient solution.  Melatonin is a pharmacological 
treatment that has been the subject of a considerable amount of childhood sleep 
management research (Blackmer & Feinstein, 2016). Melatonin is a hormone 
produced by the suprachiasmatic nucleus via sympathetic β-adrenergic receptors in 
the pineal gland that promotes normal sleep-wake cycles (Moore; 2007). Melatonin 
is released in response to night (dark) and day (light) (Moore; 2007). The natural 
production of melatonin in neurodevelopmental disorders is commonly thought to be 
impaired, resulting high rates of melatonin use in the management of sleep 
disturbance, particularly among children with ASD (Cortesi et al., 2012; Damiani et 
al., 2014; Wasdell et al., 2008). Whilst melatonin is effective, it has a number of 
limitations, including a reduction in efficacy over time, and reports of headaches, 
dizziness, rashes, cough, increased seizure activity and asthma attacks (Blackmer & 
Feinstein, 2016; Braam et al., 2013; Bruni et al., 2018). Other medications used in 
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the treatment of sleep include antihistamines, clonidine, guanfacine, and 
benzodiazapines (Felt & Chervin, 2014). 
 
Behavioural interventions. Behaviourally-based interventions are founded on 
the principles of operant behaviour and learning theories, and seek to target the 
environmental, behavioural, and cognitive causes of sleep problems (Owens, 
France, & Wiggs, 1999). These strategies emphasize the role of stimuli present 
surrounding sleep-related behaviours, including those that signal for the occurrence 
of such behaviour (i.e., antecedents), along with those that serve as positively or 
negatively reinforcement for such (i.e., consequences). Behavioural interventions are 
conventionally separated into antecedent-based procedures and consequence-
based procedures, based on which type of discriminative stimuli they address. 
Antecedent-based approaches include sleep hygiene (as described above) and 
bedtime routine modification, visual supports, social stories, sensory modulation and 
stimulus substitution, faded bedtimes with and without response cost, scheduled 
wakings and chronotherapy (Blampied & France, 1993; Jan et al., 2008). 
Consequence-based techniques include standard extinction and modified extinction 
procedures (including graduated extinction, minimal check, and parental presence), 
and multimodal treatments (Blampied & France, 1993). 
 
Antecedent-based procedures. Traditionally, behavioural sleep interventions 
begin by addressing the antecedents identified by functional assessment as being 
the discriminative stimuli preceding the problem behaviour. This is done using 
antecedent-based procedures which are formed on the principles of operant 
behaviour theory (Blampied, 2013; Skinner, 1969). They utilize stimuli that work on 
the basis that any stimuli present in the spatial and temporal vicinity of the behaviour 
will serve to reinforce said behaviour. Antecedent-based procedures may also be 
useful when attempting to chain behaviours together, such as in a bedtime routine, 
where activities and cues can be manipulated to facilitate progression to the next 
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phase of the routine. Antecedent-based interventions include sleep hygiene, visual 
supports, bedtime fading, sleep restriction, chronotherapy, and scheduled wakings. 
Of this assortment of therapies, establishment of good sleep hygiene and a bedtime 
routine, bedtime fading, sleep restriction, and bedtime scheduling has been used 
with children with RGND. The convention in behavioural sleep interventions is to 
begin with the establishment of positive sleep hygiene. 
 
Sleep hygiene modifications. Good sleep hygiene has been found to be a 
critical component of overall sleep quality over the course of one’s life (Brown et al., 
2014; Mindell et al., 2009; Spruyt & Curfs, 2015). Modification to sleep-related 
behaviours that encourage good sleep, or “sleep hygiene,” is the standard first step 
in treating sleep disturbance in children with neurodevelopmental disorders (Grigg-
Damberger & Ralls, 2013; Jan et al., 2008; Stores, 2001). In establishing good sleep 
hygiene, activities and cues associated with the sleep environment (e.g., noise, light, 
room temperature, bed position), sleep schedule (e.g., regularity of sleep and wake 
times), physiologic factors (e.g., preventing hunger, avoiding overstimulation), and 
sleep practices/bedtime routines (e.g., relaxing activities before bedtime) are 
targeted to optimize sleep (Christodulu & Durand, 2004; Gradisar & Short, 2013; Jan 
et al., 2008; Owens et al., Schreck, 2001; Vriend et al., 2011). Establishing sleep-
conducive bedtime routines is an especially important part of sleep hygiene, and 
may include any activities or rituals that are relaxing and enjoyed by the child 
(Christodulu & Durand, 2004; Kodak & Piazza, 2008; Midell et al., 2006; Schreck, 
2001). Examples of such activities include bathing, getting into pyjamas, brushing 
teeth, reading, listening to calming music, and turning out the light before bedtime 
(Christodulu & Durand, 2004; Schreck, 2001). In addition to the establishment of 
routines that promote sleep, a sleep hygiene protocol should also seek to remove 
behaviours and cues that are not conducive to sleep and that reinforce wakefulness, 
such as technology/device use leading up to bedtime (Cortesi et al., 2010; Deliens et 
al., 2015; Gradisar & Short, 2013). In many cases, good sleep hygiene is achieved 
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through a process of trial-and-error for children with neurodevelopmental disorders, 
and the presenting disorder will determine the selection of which specific techniques 
to employ (Blackmer & Feinstein, 2016). 
 
Bedtime scheduling and bedtime fading. Systematic and progressive alteration 
of bedtime can be an effective approach to the resolution of sleep onset 
delay/latency, night wakings, and early morning wakings (Piazza et al., 1997). Faded 
bedtime procedures close the temporal gap between one’s bedtime and the time of 
their actual sleep onset, after which the bedtime is shifted forward in a sequential 
manner until a developmentally appropriate bedtime is attained (Mindell et al., 2006). 
A time at which a child will naturally fall asleep after 15 minutes of being put to bed is 
identified through assessment and baseline measures. With the commencement of 
treatment, a new bedtime introduced which aligns with this natural sleep time. The 
child’s bedtime is then methodically brought forward to an earlier time over the 
course of treatment, whenever they have progressed to the point of reliably falling 
asleep within a few minutes of their designated bedtime (Kodak & Piazza, 2008; 
Richdale & Wiggs, 2005; Turner & Johnson, 2012; Vriend et al., 2011). As an 
alternative method, bedtime scheduling involves the enforcement of a nominated 
sleep and wake time (Piazza et al., 1997). A child partaking in bedtime scheduling is 
not permitted to sleep outside of their predetermined bedtime and morning wake 
time. If the child fails to fall asleep in this sleep period, they are prevented from 
sleeping until their next designated sleep period (Piazza et al., 1997).  In both faded 
bedtime and scheduled bedtime procedures, children must be woken at a scheduled 
time in the morning and they must be prevented from sleeping during the day, as 
unplanned additional sleep will likely interfere with the goals of this intervention 
(Vriend et al., 2011). 
 
While sleep hygiene implemented in isolation is not sufficient to resolve sleep 
problems completely, the effectiveness of other sleep intervention procedures is 
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contingent on the establishment of good sleep hygiene (Jan et al., 2008; Johnson, 
Giannotti, & Cortesi, 2009; Mindell, Telofski, Wiegand, & Kurtz, 2009; Singh & 
Zimmerman, 2015; Vriend et al., 2011). Modification to a child’s sleep hygiene is 
thus generally carried out together with additional behavioural strategies tackling the 
antecedents preceding the problematic sleep behaviour, such as bedtime scheduling 
and bedtime fading.  
 
Consequence-based procedures. Directing focus toward the consequence 
element of the A-B-C framework of the behavioural model of operant behaviour 
theory (Blampied, 2013; Skinner, 1969), consequence-based interventions 
concentrate on the factors immediately following an undesired behaviour. Such 
procedures function through the manipulation of these factors in order to decrease 
the incidence of the problematic behaviour in future (Wiggs & France, 2000). Some 
common consequence-based procedures used in the treatment of sleep disturbance 
include extinction or modified extinction procedures (e.g., standard extinction, 
graduated extinction, minimal check, and parental presence), and reinforcement 
schedules.  
 
Extinction or modified extinction procedures. The standard extinction procedure 
addresses sleep problems related to settling and night waking, where functional 
behaviour assessment has concluded that the behaviour serves to instigate or retain 
parental attention (Didden et al., 1998). Extinction necessitates the consistent 
withholding of social reinforcement that has previously served as a factor maintaining 
undesired behaviour (Didden et al., 2002; Owens et al., 1999; Turner & Johnson, 
2012; Vriend et al., 2011). A traditional extinction procedure would consist of the 
parent only attending to/engaging with the child when absolutely necessary (e.g., if 
the child’s safety or health is in question), and otherwise ignoring the child’s 
behaviour until an appropriate morning wake-time (Owens et al., 1999; Turner & 
Johnson, 2012, Vriend et al., 2011). In essence, parents would be required to avoid 
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responding to any sleep-resistant behaviour such as tantrums, crying, calling out, or 
leaving the bedroom (Allen et al., 2013). The anticipated result of the intervention is 
that problematic behaviour including bedtime resistance, sleep onset delay, and 
night wakings will no longer occur (Vriend et al., 2011).  
 
Behavioural approaches are currently considered the gold standard in 
treatment of childhood sleep disturbance (Mindell et al., 2006b; Morgenthaler et al., 
2006). Aside from their proven efficacy, behavioural intervention procedures have 
been shown to have greater social acceptability, due to longer-lasting effects, fewer 
negative side effects, the potential for treatment effects to generalize to daytime 
problems, and increased parental self-efficacy and coping abilities (Grigg-Damberger 
& Ralls, 2013; Stores, 2001). 
Sleep Treatment in RGND 
Despite the growing empirical support for the use of behavioural interventions 
in the treatment of sleep disturbance in typically developing children (Mindell et al., 
2006b; Morgenthaler et al., 2006) and children with ASD (Richdale, 2013), medical 
and pharmacological approaches are typically opted for in cases involving children 
with RGND. This is evidenced by the comparatively abundant literature which 
investigates medical and pharmacological treatments (Bailey et al., 2012; Braam et 
al., 2008; Wong et al., 2015). For example, in a survey by Wong et al., (2015) it was 
evident that 43.4% of parents of children with Rett syndrome chose to treat their 
child’s sleep problems through non-specific sleep medications and 28.3% through 
sleep medications. Conversely, only 12% of respondents choose to implement non-
pharmacological treatments (Wong et al., 2015). This is in spite of the evidence that 
parents have trepidation over the side-effects that come with various medications, 
and their effectiveness in the long-term (Bramble, 1996). Underlying the preference 
for medications may be the fact that health professionals or parents often attribute 
sleep problems to being characteristic of the disorders themselves (i.e., as an 
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eventuality of cortical or chemical abnormalities) and therefore do not consider 
behavioural interventions appropriate (Allen et al., 2013; Walz, Beebe & Byars, 2005; 
Pelc et al., 2008). Furthermore, the lack of empirical evidence demonstrating the 
efficacy of behavioural approaches to sleep problems in children with RGND is likely 
to deter their implementation. It is important to note that the research that does exist 
which explores the effects of behaviourally-based treatments for sleep problems is 
promising. This research is reviewed extensively in chapter two of this thesis. Whilst 
these studies indicate the promising effects of behavioural treatments, further 
research in this area is required. 
Functional Behaviour Assessment 
Implementing an intervention without the function of the challenging behaviour 
being targeted is an ill-informed approach, and will likely lead to less effective 
treatment outcomes (Hanley, 2016). In many cases, treatments are prescribed 
based on surface evaluation of a problem behaviour, without careful consideration of 
purpose or function that the behaviour is serving (Brown & Piazza, 1999; Hanley et 
al., 2003). The result of treatments that do not consider the antecedents and 
consequences of the behaviour and how these factors may be functioning to 
facilitate to preservation of said behaviour, is merely modification without necessarily 
resolving the issue (Campbell, 2003; Hanley, 2016; Horner et al., 2002). Not to 
mention that ineffective treatments waste time, money, and can be distressing and 
disheartening to the child and family involved. Promisingly, the empirical evidence 
supporting interventions based on functional behaviour assessment (FBA; Brown et 
al., 2013; Didden & Sigafoos, 2001; Hanley, 2016; Hanley et al., 2014; Kodak & 
Piazza, 2008) is increasing in the field of clinical behavioural intervention.  
 
Definition and process of functional behaviour assessment. An application of 
operant behaviour theory that has proven to be an effective tool in the elimination of 
problem behaviours is Functional Behaviour Assessment (FBA; Beavers, Iwata, & 
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Lerman, 2013; Blampied, 2013; Brown et al., 2013; Hanley et al., 2014; Hanley, 
2016; Horner et al., 2002; Kodak & Piazza, 2008). FBA is a procedure through which 
the most pertinent discriminative stimuli and contingencies causing and maintaining 
the behaviour of interest are identified and used to inform treatment planning. The 
logic behind the approach is that one can alter a behaviour by manipulating the 
antecedents and consequences that either precede or follow it (Horner et al., 2002). 
The FBA process involves gathering information from a variety of sources regarding 
the problem behaviour and then using that information to generate a hypothesis 
concerning the function of the behaviour (Blampied, 2013). Interviews, checklists, 
ratings, self-report measures, questionnaires are among some of the tools used to 
compile objective information about the antecedents and consequences working to 
facilitate and encourage undesirable behavior (Blampied, 2013). Additionally, direct 
observations are utilized in FBA to provide insight into how the problem behavior 
presents in natural contexts (Blampied, 2013). The comprehensiveness of this 
assessment procedure enables inferences to be made regarding the factors that 
may be causing and maintaining the behavior in question. From there, evidence-
based intervention procedures that address the various antecedents and 
consequences enveloping the behavior can be selected (Blampied, 2013; Horner et 
al., 2002). 
 
The FBA process accounts for the fact that the aetiology of problematic 
behaviour is multifactorial, and henceforth it takes heed in ensuring not to confine a 
challenging behaviour to traditional categorisations, diagnositic labels, or norms 
(Horner et al., 2002; Blampied, 2013; Brown & Piazza, 1999; Kodak & Piazza, 2008). 
Additionally, in undertaking FBA the focus is set on present and recent occurrences 
related to the problem behaviour, rather than those of the past (Blampied, 2013). 
 
Functional Behaviour Assessment for sleep problems. There are a number of 
examples of the use of FBA to inform the treatment of challenging behaviour in 
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typically developing children and children with developmental disabilities, including 
RGND (Anderson, Rodriguez, & Campbell, 2015; Arndorfer & Miltenberger, 1993; 
Radstaake et al., 2013). There are also a small number of examples in which FBA 
has been used successfully to inform the treatment of sleep problems in children 
(Blampied, 2013; Jin et al., 2013; McLay et al., 2017; Moore et al., 2004; 
Papadopoulos et al., 2015). The information obtained about sleep difficulties in FBA-
informed sleep treatment comes predominantly from sleep diaries, but also through 
interviews, video analysis, and parent-report questionnaires (Blampied, 2013). 
Interviews are an efficient way to build a picture of the sleep disturbance (i.e., the 
frequency, duration and intensity), the setting/s that the sleep-related behaviour 
takes place within, and the preceding and consequent stimuli that frequently occur 
around the sleep problems (Blampied, 2013). An interview can also be used to 
procure other contextual information (i.e., developmental history, past intervention 
attempts) that might further ones understanding of the sleep disturbance and 
subsequently aid in the development of a treatment plan (Blampied, 2013). Parental 
preferences, concerns, and thoughts about their child’s sleep are some other 
valuable details that can be uncovered through interviewing and can provide an 
opportunity for rapport-building between families and health professionals 
overseeing treatment (Blampied, 2013). Supplementary to interviews, parent-report 
questionnaires are also commonly administered to gain objective identification of the 
specific sleep problems at hand, and measurement of its frequency, duration, and 
intensity where appropriate (Blampied, 2013). Assessment packages in FBA of sleep 
disturbance often contain the Sleep Assessment and Treatment Tool (SATT; Hanley, 
2005), Child Sleep Habits Questionnaire (CSHQ; Owens, Spirito, & McGuinn, 2000), 
and the Questions About Behavioural Function (QABF; Matson & Vollmer, 1995) 
questionnaires. 
 
Direct measures comprise parent-reported sleep diaries and observations in 
the form of video recordings of children during the night (Blampied, 2013; Hanley et 
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al., 2014). Sleep diaries provide parental report of instances of sleep disturbance 
and may request description of the type (e.g., sleep-resistant behaviour, curtain 
calls, night-time wakings), frequency, duration, and context of sleep problems, in 
addition to any responsive action on the parents’ part. Video recordings enable the 
first-hand viewing of sleep problems as they occur typically for the child (Blampied, 
2013). Information of this kind can be used to validate parental report, and uncover 
any behavior that parents are not aware of (Jan et al., 2008; Richdale & Schreck, 
2009). The aforementioned direct and indirect measures are used in conjunction to 
build a comprehensive picture of the problematic sleep behaviour, prevent reporting 
bias, and establish treatment effects via ongoing or repeated measurement (Knight & 
Johnson, 2014; Spruyt & Curfs, 2015). 
 
Once all necessary information is accumulated through the various assessment 
techniques, a treatment plan that takes into account all that has been uncovered can 
be crafted to address the individual’s personal sleep problems (Blampied, 2013). 
Antecedents and consequences that are typically identified as being maintaining 
factors in cases of childhood sleep disorders include poor sleep hygiene, parental 
presence at sleep onset, possibility of procuring desirable tangible items, and self-
stimulatory behaviours. From there, a treatment plan would be developed based on 
the findings of the FBA. For instance, if it was suspected that the function of a 
presentation of co-sleeping was to gain attention from a parent, then the treatment 
approach would be to remove parental attention at times where the child would be 
falling asleep, or going back to sleep following a night waking.  
 
Given that functional assessment places emphasis on recent behaviour and 
events (Blampied, 2013), it is often necessary to amend portions of the treatment 
plan over the course of intervention, to ensure that all treatment techniques continue 
to serve their purpose in addressing the function of the behaviour. In this sense, 
repeated measurement of sleep outcomes throughout baseline and treatment 
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phases using direct methods (i.e., sleep diaries and video recordings) is critical. In 
addition to making sure that intervention is responsive to the changing needs of the 
individual as they progress or regress in treatment, it is important that intervention 
approaches be kept to a minimum, only including techniques that are actively 
producing positive outcomes. Intervention procedures that become redundant at any 
point during treatment should be removed or discontinued.  
 
Following an FBA-based sleep intervention, it is advisable to carry out a 
measure of social validity to gain insight into the family’s thoughts about the 
intervention, their level of comprehension with respect to approaches used, any 
secondary effects that they observed relating to their child or themselves, their level 
of satisfaction with the treatment outcomes, and any recommendations they might 
offer (Finn & Sladeczek, 2001; Hanley et al., 2014). The greater the social validity of 
an intervention, the more likely it is that parents will adhere to treatment plans, and 
henceforth promote superior treatment outcomes (Brown et al., 2013). The 
Treatment Acceptability Rating Form (TARF-R; Reimers & Wacker, 1992) is a 
questionnaire designed for this purpose, and may be preferable to a semi-structured 
interview format, where parents may be less likely to offer honest opinions whilst 
face-to-face with a figure involved with the intervention. Establishing social validity is 
in keeping/compatible with the principles of FBA, as it maintains the emphasis 
around gathering information from various sources to inform treatment. While it is a 
measure obtained post-treatment and obviously cannot be used to develop the now 




As is stipulated by the systems perspectives of human development, a child 
grows within the confines of multiple interrelated biological, psychological, social, 
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and cultural contexts (Bronfenbrenner & Morris, 2006; Ford & Lerner, 1992; Lerner, 
2006). In an application of this theory, it may be posed that a child’s familial system 
is partially responsible for modeling, shaping, and maintenance of problematic 
behaviour (Wahl, Johnson, Johansson, & Martin, 1974). With this being the case, it 
is important for the family context (particularly parent-child interactions) to be 
examined in the assessment of problem behaviour for intervention. Then in the same 
way that the family system aids in the development of maladaptive behaviour, it 
likewise plays a crucial role in the reversal of such behavioural challenges. Given 
that sleep typically occurs in the home, amongst family members residing in the 
shared space, parents are instrumental in the implementation of sleep interventions. 
In a review of the literature, Carr and colleagues (1999) found that treatment success 
was 37% more likely with behavioural interventions implemented by familiar support 
figures such as parents or teachers and carried out in natural settings, compared 
with interventions conducted by “atypical” support agents.  
 
It is important that treatment plans are deemed socially acceptable by the 
parents who will be charged with the implementation of the plan, if the desired 
treatment outcomes are to be achieved (Moore, 2004; Turner & Johnson, 2012). 
Functional behaviour assessment requires the perspectives of the family to be 
gathered and henceforth enables/promotes the procurement of parental knowledge, 
preferences, goals, in addition to any cultural or ethical standpoints that should be 
incorporated in the resulting treatment design (Jin et al., 2013). Seeking familial input 
when designing interventions can assist in ensuring parents’ adherence to 
interventions, as they are likely to feel that they have greater agency over the 
endeavor given that they were actively involved from the beginning (Blampied, 2013; 






The purpose of this review is to appraise the scope of the existing/extant 
intervention research targeting/covering/on sleep disturbance experienced by 
children with RGND. Literature discussing both behavioural and pharmacological 
evidence-based treatment methods within this population is examined at length, 
including melatonin, human growth hormone (GH) replacement therapy, 
Diphenhydramine HCI, bedtime fading, bedtime scheduling, reward systems, 
extinction, desensitization procedures, psychoeducation, “Excuse-me” drill, sleep 
hygiene, sleep environment, prevention of daytime napping, and visual aids. Many 
multi-component interventions. The review closes with a summary of the findings 
and the state of the literature discussed, followed by the rationale for the current 
study. 
Search Process 
Given the relative scarcity of empirical research published on/regarding 
evidence-based behavioural procedures, this review also covers non-behavioural 
interventions in order to develop a more comprehensive understanding of the 
customary treatment approaches exercised with children with RGND for their sleep 
difficulties. The selection of RGNDs included in this search was decided based on a 
comprehensive internet search, as well as correspondence with individuals via the 
PedSleep forum. Their resulting list of RGNDs to include were FXS, AS, RTT, SMS, 
Williams syndrome, Cri-du-chat syndrome, Turner syndrome, DiGeorge syndrome 
(velocardiofacial syndrome or 22q11.2 deletion syndrome), Sotos syndrome, septo-
optic dysplasia, PWS, and agenesis of the corpus callosum. Additional syndromes 
were also added if later identified during literature searching, though this was not the 
case. As with the McLay and colleagues’ (2019) search procedure, developmental 
disabilities that were deemed degenerative, proliferative, or resulting from infection 
or environmental causes were excluded from the search list, as were disorders that 
	 46	
did not feature developmental or intellectual disability (e.g., epilepsy). Inclusion 
required that an article (a) be published in and English-language, peer-reviewed, 
academic journal; (b) involve at least one participant with a primary diagnosis of 
RGND that was under the age of 18; (c) employ a behavioral treatment (Cooper, 
Heron, & Heward, 2007); and (d) report quantitative data on sleep-related treatment 
outcomes.  
 
PsychINFO, PsychARTICLES, Psychology and Behavioural Sciences 
Collection, and Education Resources Information Centre (ERIC) were the electronic 
databases used to conduct the literature search. Search terms input into the above 
databases were ‘sleep’, keywords relating to intervention (“treatment”, “intervention”, 
“therapy”), and the names of each listed RGND individually. Finally, an ancestry 
search was conducted for the articles that had been detected during initial database 
searches.  
Pharmacological Interventions for Sleep Disturbance in Children with RGND 
Melatonin. There were five articles sourced that treated sleep disturbance in 
children with RGND with melatonin. The studies describe participants ranging from 
two to 20 years of age, and included diagnoses of AS, Smith-Magenis syndrome, 
and RTT. Sleep onset latency, night wakings, and reduced total sleep time are 
among the sleep difficulties treated by melatonin in the studies found.   
 
 Braam and colleagues (2008) randomly assigned 8 children with AS between 
ages four and 20 to a treatment or placebo-controlled group. The former was 
administered 2.5 mg/5 mg (age-dependent) of melatonin mixed with 
carboxymethylcellulose in a fast-release tablet, and the latter were given an 
identical-looking placebo. Participants received melatonin treatment for a period of 
four weeks, during which time average sleep onset latency decreased by 32 
minutes, and average total sleep time increased by 56 minutes. Night wakings 
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decreased from a mean of 3.1 to 1.6 over the course of a week. These results 
contrast with those of the placebo control group, who experienced an average 
decrease in SOL of .75 minutes, an average decrease in total sleep time (TST) of 9 
minutes, and a reduction in average number of night wakings from 1.7 to 1.8 (Braam 
et al., 2008). Additionally, the authors conducted an open treatment trial with 20 new 
participants, and observed a lessening in therapeutic gain in some participants by 
the fourth week of treatment. In these cases, salivary endogenous melatonin levels 
had become exceptionally high, to the point where normal melatonin rhythms had 
been expunged (Braam et al., 2008).  
 
In another study targeting 13 children with AS (aged two to 10), Zhdanova and 
others (1999) implemented a daily treatment of a 0.3 mg dose of melatonin. Blood 
samples were taken every hour for two 21-hour periods, one pre-treatment and one 
during treatment, to establish the participants’ individual endogenous serum 
melatonin levels and the levels brought about by melatonin treatment, respectively. 
Actigraphy was also used to measure motor activity 24 hours per day for seven days 
prior to treatment and then five days during treatment, corroborated by parent 
recorded sleep diaries. The results indicated that melatonin treatment had 
significantly improved the participants’ sleep, with a notable reduction in motor 
activity during specified sleep periods and an increase in total sleep time overall. 
Parents of the participating children noted a decrease in SOL and a lowered 
susceptibility to being woken by noises in and around their sleep environment 
following the commencement of melatonin treatment (Zhdanova et al., 1999).  
 
In a randomized, double-blind, placebo-controlled trial, Gringas and others 
(2017) assessed the utility of PedPRM (a prolonged-release melatonin) in treating 
sleep problems in a sample of 125 children between the age of two to 17.5. Within 
their participant group/pool 96.8% had ASD and 3.2% (four children) had Smith-
Magenis syndrome. The children received either a 2/5mg dose of PedPRM over the 
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course of 13 weeks, or a placebo. A “Sleep and Nap Diary,” composite sleep 
disturbance index (CSDI), and actigraphy were included as measures of treatment 
effects. By the end of the 13-week treatment period, TST increased on average by 
57.5 minutes in the treatment group. Contrastively, the placebo group demonstrated 
an average increase in TST of 9.14 minutes. The treatment group also showed 
improvement in SOL, with a mean decrease of 39.6 minutes, compared to a mean 
decrease of 12.5 minutes in the placebo group. CSDI scores indicated a decrease in 
overall sleep disturbance amongst treatment group participants (Gringas et al., 
2017).  
 
Nine girls with RTT with a mean age of 10.1 years were prescribed 2.5 to 7.5 
mg of immediate release melatonin or placebo in a double-blind, placebo-controlled, 
crossover study with randomized treatment order (McArthur et al., 1998). Sleep 
onset latency and total sleep time data were gathered through actigraphy and sleep 
diaries during one week of baseline assessment, the 1st four-week treatment 
regimen, a one-week “wash-out” period, and a second four-week treatment period 
using the alternate medication. With regard to SOL, the treatment group showed a 
considerable decrease within the first three weeks of treatment, with improvement 
noticeable during the first nights of melatonin supplementation in a number of 
instances (McArthur et al., 1998). Gains in TST were detected for the three 
participants who had the poorest sleep efficiency at baseline. The group mean TST 
was not statistically significant however, nor were the mean group differences. 
Frequency of night wakings were similarly unaffected by melatonin treatment in this 
sample. Overall, there was considerable variability in the individual responsiveness 
to the melatonin treatment and the subsequent improvement in sleep outcome 
variables across participants (McArthur et al., 1998).  
 
Miyamotoe and colleagues (1999) describe their treatment of a seven-year-old 
(patient 1) and a 13-year-old girl (patient 2) with RTT and sleep disturbance, using 
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melatonin. Patient 1 demonstrated a free-running sleep-wake cycle (i.e., sleep 
pattern that does not adhere to the typical 24-hour cycle in humans) prior to 
treatment, while patient 2 displayed a fragmented sleep pattern and parasomnia 
characterized by night screaming. Both girls were administered 5 mg of melatonin 
and blood samples were drawn at hourly intervals which were were then examined 
through radioimmunoassay every few months for blood cell counts, urinalysis, serum 
chemistry, luteinizing hormone, follicle-stimulating hormone, prolactin and estradiol. 
In the case of patient 1, a normal sleep-wake cycle was established and progress 
was maintained after two years. Free-running sleep onset reemerged on occasion 
when melatonin supplementation was suspended, however these cleared up when 
melatonin treatment was reinstated. Patient 2 was consistently falling asleep within 
30 minutes of taking melatonin each night, thus demonstrating some improvement in 
sleep pattern. However, early morning wakings did not improve with treatment and 
fragmented sleep returned when treatment stopped (Miyamoto et al., 1999). 
 
Other medications. Two articles were found that addressed non-melatonin 
pharmacological interventions, namely human growth hormone (GH) replacement 
therapy and diphenhydramine HCI. The two articles presented single case 
descriptions of a 5-year-old girl with Smith-Magenis syndrome, and a 9-year-old boy 
with AS. The sleep disturbance exhibited in these two cases included early morning 
wakings, reduced total sleep time, and daytime sleep. 
 
A single-case study conducted by Itoh and others (2004) reports on the 
elimination of sleep disturbance of a 5-year-old girl with Smith-Magenis syndrome 
who received human growth hormone (GH) replacement therapy for dwarfism. The 
particular variables of interest were sleep-wakefulness circadian rhythm, which were 
measured through direct observation on a daily basis and polysomnography for one 
night four months before and one night four months after treatment. Morning wake 
times shifted from an average time of 4-4.30am before treatment was introduced to 
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approximately 6am. TST also improved, increasing from a mean of 399 minutes pre-
treatment to 502 minutes. Low percentage of REM sleep before treatment was 
increased following human growth hormone (GH) replacement therapy, specifically 
from 2 to 5 REM episodes (Itoh et al., 2004).  
 
Using a treatment package consisting of both pharmacological and behavioural 
components, Summers and colleagues (1992) treated a 9-year-old boy with AS who 
was experiencing sleep problems. Diphenhydramine HCI was prescribed, and the 
behavioural procedures put in place included restriction of daytime sleep, 
establishing a consistent sleep schedule, and reducing parent-child interactions 
during sleep onset and night wakings. The intervention was conducted at an 
inpatient behavioural treatment unit primarily and implemented by staff, however the 
treatment setting was transferred to the participant’s home after 55 days of 
treatment, implemented from then on by his parents. TST increased from a mean of 
1.9 hours per night and 1.3 hours during the day at baseline to a mean of 8.3 hours 
per night and .8 hours during the day. Following these results, medication was 
stopped, and subsequently TST decreased slightly to a mean of 7.8 hours during the 
night and .7 hours during the day. Treatment effects were maintained at a 45-day 
follow-up, with a mean TST of 7.1 hours at night and .29 hours during the day 
(Summers et al., 1992).  
 
The small body of existing research examining pharmacological treatments for 
sleep problems in children with RGND points to the short-term effectiveness of 
medications such as melatonin, human growth hormone (GH) replacement therapy, 
and Diphenhydramine HCI. Across the studies, improvement was observed in the 
participant’s sleep behaviours following treatment. This improvement was greater for 
treatment groups compared with placebo control groups. The only exception to these 
results was found by McArthur and others (1998), for whom results were mixed for 
TST and night wakings.  
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Two studies utilized a randomized, double-blind, placebo-controlled trial 
(Gringas et al., 2017; McArthur et al., 1998), which is deemed the ‘gold standard’ 
research design for drug trials due to its ability to reduce bias, balance participant 
characteristics between groups, and provide insight into the cause-effect relationship 
between treatment and outcome (Hariton & Locascio, 2018). One study implemented 
a randomized, placebo-controlled trial (Braam et al., 2008), and four studies followed 
a single-case research design (McArthur et al., 1998; Miyamoto et al., 1999; 
Summers et al., 1992; Zhdanova et al., 1999). Although these studies describing 
single cases are not protected from bias, they do allow for the examination of causal 
relationships due to their comprehensiveness. The overall high quality of the 
research designs used subsequently lends credibility to the findings of these studies. 
Importantly however, the long-term maintenance of initially positive treatment was 
largely unexplored. The studies that did conduct long-term follow-up of effects found 
mixed results, with Summers and others (1992) observing sustained improvement, 
and Miyamoto and colleagues (1999) seeing a return to pre-treatment levels of sleep 
disturbance. 
Behavioural Interventions for Sleep Disturbance in Children with RGND 
Six articles were uncovered that described the treatment of children with RGND 
using behavioural interventions. The participants in these studies ranged from 2 to 
18 years old and had RGND diagnoses of PWS, FXS, AS, and Williams syndrome. 
The behavioural procedures implemented across the included articles were faded 
bedtime with a response cost, bedtime scheduling, graduated and non-graduated 
extinction procedures, parental psychoeducation, modification to sleep environment, 
manipulation of sleep/wake schedule, “Excuse Me Drill”, visual aids, reinforcement 
procedures, and prevention of daytime napping. The types of sleep problems treated 
with the aforementioned procedures included SOL, night wakings, early morning 
wakings, co-sleeping, sleep-related anxiety, bedtime resistance, difficulty 
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independently initiating sleep without parental presence, and excessive daytime 
napping. 
 
In a study of 14 participants (including one child with PWS) aged from 4 to 14, 
a behavioural treatment involving faded bedtime with a response cost (the response 
cost being to remove the child from bed and keep them awake for one hour when the 
child did not fall asleep within 15 minutes of their bedtime), or bedtime scheduling 
was employed to treat sleep difficulties (Piazza, Fisher, & Sherer, 1997). Participants 
underwent a baseline period, followed by one of the two behavioural treatment 
procedures, to which each child was randomly assigned. Measures that were taken 
at pre- and post-treatment to evaluate treatment efficacy comprised direct 
observation through momentary time sampling over 24 hours at every half hour 
interval, and a global measure of sleep disturbance, which was calculated by adding 
the duration of sleep that occurred outside of appropriate sleep times plus the 
duration of wake time that took place within the defined appropriate sleep time. 
Within the bedtime scheduling group, the mean hours of disturbed sleep decreased 
from 1.37 during baseline to 1.10 hours post-treatment, however this effect was not 
significant. For the group that were prescribed a faded bedtime procedure (with 
response cost), the mean hours of disturbed sleep decreased to a significantly 
greater degree, beginning with 1.44 hours at baseline and ending treatment with 
0.53 hours of disturbed sleep. The child with PW had presented with some very early 
morning wakings and some night wakings, both of which improved greatly following 
his faded bedtime with response cost. Of particular note was the finding that it was 
daytime sleep was only able to be eliminated once the faded bedtime was coupled 
with the response cost, signifying the importance of this intervention component.  
 
Didden and others (1998) implemented behaviourally-based interventions with 
six boys ranging from two to seven years of age. Within the participant group, there 
was one boy with PWS presenting with settling difficulties and night wakings, and 
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one boy with FXS presenting with sleep-related anxiety and co-sleeping. During a 
baseline phase, interviews and sleep diaries were completed which informed a 
functional analysis conducted for each of the children to ascertain the function of 
their problematic sleep behaviour and point to potentially effective solutions. 
Throughout all phases of the study, parents took note of the number of minutes that 
target behaviours occurred on recording sheets. The children then went through a 
treatment phase that varied in duration across participants between 45 to 55 nights. 
For the boy with PWS, treatment followed an AB-design (comprising a baseline 
phase followed by treatment) and consisted of a non-graduated extinction procedure 
wherein his parents bid him goodnight and then left him alone until morning. This 
technique was combined with the provision of positive attention in morning when he 
had remained quiet during the night. The behavioural techniques used to treat the 
boy with FXS were a desensitization procedure coupled with differential 
reinforcement of positive behaviour, as his functional assessment had indicated that 
his sleep problems were rooted in anxiety. For this boy’s intervention, a B-design 
was followed (treatment phase followed by the cessation of intervention, before then 
reinstating intervention a second time). A clear, consistent, and calming bedtime 
routine was put in place. The child’s bedtime routine consisted of 19 steps, including 
being taken to bed at 8pm, and his mother reading him a story in bed before being 
left to sleep. If he kept quiet and complicit for the entire duration of a step, he earned 
a preferred edible reward, and then they would continue with the next step in his 
routine. If he failed to do this during any step, his mother would stay with him in his 
bed until morning. The study included a follow-up period of about five days 
approximately six months after treatment had ended. The results for the participant 
with PWS showed a decrease in the number of minutes of nighttime disruption from 
an average of 90 minutes at baseline to an average of 22 minutes’ post-treatment, 
and a further decrease to zero minutes at follow-up. The participant with FXS 
demonstrated a sudden increase in inappropriate bedtime behaviour with the 
reinstatement of intervention, followed subsequently by the successful completion of 
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the last step in his bedtime routine, along with the elimination of co-sleeping and all 
symptoms of anxiety (Didden et al., 1998).  
 
Another study which carried out a multi-component behavioural treatment 
package was led by Allen and colleagues (2013). Through a multiple baseline design 
across participants, five children between 2 and 11 years with AS were assessed for 
co-sleeping, bedtime resistance, and night wakings using sleep diaries and 
actigraphy before individualized treatment packages were developed to optimize 
their sleep environment, sleep-wake schedule, and any parent-child interactions 
during sleep times. Some of the treatment techniques included delayed bedtimes, 
sleep restriction during the day, extinction procedures, and in cases where parents 
did not feel comfortable with the standard extinction procedure, a modified extinction 
procedure known as the “Excuse-Me Drill” was implemented. The “Excuse-Me Drill” 
involves periodic checking in on children in the time before sleep onset and during 
night wakings, contingent on the child’s demonstration of calm and quiet behaviour 
whilst staying in bed (Allen et al., 2013; Kuhn, 2011). In this way, parental attention 
and presence is purposefully utilized to reinforce sleep-conducive behaviour and 
provide the opportunity for self-soothing skills to be practiced, and subsequent 
independent sleep initiation at bedtime and reinitiation to take place in response to 
night-time wakings (Allen et al., 2013). The authors also requested that parents 
establish a sleep-compatible environment by keeping visual and auditory stimuli to a 
minimum (i.e., turning off television and stereo), removing any light sources to create 
a no light or low light setting, and adjusting the room temperature if needed. 
Following the commencement of treatment, all five participants showed decreases in 
disruptive behaviour and independent sleep initiation over the next month. Prior to 
intervention, all participants needed their parents to be with them in order to fall 
asleep. Within the first week of treatment, the children were all falling asleep 
independently. Throughout treatment and follow-up these effects were found to be 
stable and maintained (Allen et al., 2013).  
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Moss and others (2014) trialed the “Sleepwise” program (O’Connell, 2005) to 
address sleep problems of children with various developmental disabilities. 26 
children between 8 to 18 years of age, of whom 5 were listed to have diagnoses of 
“syndromes including Angelman, Down and others”. The participants were 
randomized to a treatment or the wait list control group. The researchers measured 
child sleep habits using the Child Sleep Habits Questionnaire (CSHQ; Owens, 
Spirito, & McGuinn, 2000), child daytime behaviour with the Developmental 
Behaviour Checklist: Parent Version (DBC-P; Einfeld & Tonge, 2002), and parent 
stress with The Parenting Stress Index: Short Form (PSI-SF; Abidin & Brunner, 
1995). Outcome measures were administered prior to the commencement of 
intervention (week 1), and post intervention at week 10 and week 18. The Sleepwise 
program (O’Connell, 2005) that was was implemented with each of the participants 
included is a manualised intervention for sleep disturbance, and is formulated 
designed for youth with developmental delay. The program first involved two 3-hour 
educational workshops that provided psychoeducation about sleep, atypical sleep, 
and sleep treatment. Second, a comprehensive sleep assessment was undertaken, 
which included an interview. Lastly, an individualized program and plan was 
developed for each child using the information gathered through assessment. 
Average total sleep disturbance scores in the treatment group decreased from 56.20 
at baseline to 46.50 post-treatment. This compared to the wait-list control group 
scores which showed no significant change (51.38 pretreatment and 51.12 at post-
treatment). Total Problem Behaviour scores decreased from 66.20 at baseline to 
57.70 post-treatment in the treatment group, which contrasts with average scores of 
72.29 at baseline and 69.25 post-treatment in the wait-list control group. These 
results indicate that daytime problem behaviour was no significantly changed as a 
result of treatment. PSI scores similarly showed no significant change from over the 
study phases in either group (Moss et al., 2014).  
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Multi-component behavioural interventions were formulated for a group of 
children with a mean age of 5 who had various developmental disabilities and were 
suffering from sleep disturbance (Weiskop et al., 2005). 7 of the 13 participants had 
FXS. The participants were initially assessed through an interview and sleep diaries 
and a functional assessment was completed. The study then followed a concurrent 
multiple baseline design, and began with a period of baseline, followed by at least 
seven weeks of treatment, and a 2-week follow-up period 3 months posttreatment. 
Sleep diaries were completed during all study phases by parents, who recorded the 
number of pre-sleep disturbances per week, number of nights per week that the child 
fell asleep alone in their own bed, average sleep latency, number of night wakings, 
number of nights per week that the child co-slept, and the average duration of night-
time sleep. The intervention itself entailed 3 weekly individual parent-training 
sessions which covered topics such as goal setting, the principles of learning theory, 
the role of antecedents and consequences, individualized bedtime schedules and 
routines, reinforcement procedures, visual aids, partner support strategies, extinction 
techniques, and general psychoeducation around sleep. The participating families 
had weekly contact with therapist for support and guidance. Complete data was 
obtained from 5 of the participants with FXS. The results showed an overall 
improvement with regard to independent sleep initiation, co-sleeping, and night 
wakings across participants for whom these were presenting issues. The treatment 
effects appeared to have been maintained at follow-up for most participants. It 
should be noted however that these positive treatment effects emerged quickly 
following the introduction of an extinction procedure (Weiskop, Richdale, & 
Matthews, 2005). 
 
Montgomery, Stores, and Wiggs (2004) delivered a behavioural sleep 
intervention to 66 families with severe learning disabilities including Angelman 
syndrome (n=2), Williams syndrome (n=1), and Fragile X syndrome (n=1), wherein 
parents were educated regarding good sleep habits. Sleep hygiene topics that were 
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covered included “creation of an appropriate sleep environment, prevention of 
daytime napping, the importance of clear routines, putting children to bed while 
awake but drowsy, removal of bottle, as well as how to deal with possible physical 
contributors of sleep disturbance (e.g., wet nappies, being too cold/hot). Following 
treatment, which also involved further psychoeducation, including information about 
extinction, and reinforcement procedures, a significant portion of the participating 
children demonstrated improvement in their sleep onset latency and night wakings. 
Those who had initially taken more than 30 minutes to fall asleep on at least 5/7 
nights, reduced a sleep onset latency of only a few minutes, and/or demonstrated 
significant sleep onset delay only once or twice per week. A similar pattern of change 
was found for night waking in this group. Maintenance of these treatment gains was 
discerned at a three-month follow-up (Montgomery, Stores, & Wiggs, 2004). 
 
The literature described above has demonstrated the effectiveness of 
behaviourally-based interventions used to treat children with RGND presenting with 
sleep problems. The positive treatment effects observed were also found to be 
maintained at follow-up in each of the studies which included follow-up assessment 
(Allen et al., 2013; Montgomery, Stores, & Wiggs, 2004; Weiskop, Richdale, & 
Matthews, 2005). Despite the strengths of this body of literature, which include the 
use of comprehensive assessment protocols using reliable and valid objective and 
subjective measures (and FBA in two instances; Didden et al., 1998; Weiskop et al., 
2005), the implementation of multi-component intervention packages comprising 
empirically supported treatment procedures, and high quality methodological 
approaches, including randomization to treatment or control groups (Didden et al., 
1998; Moss et al., 2014;, Piazza, Fisher, & Sherer, 1997) and multiple baselines 
(Allen et al., 2013; Weiskop et al., 2005), it is not without it’s limitations. 
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Limitations of the Literature  
Several methodological limitations should be considered when interpreting the 
existing research on this subject of behaviourally-based sleep interventions in their 
use with children with RGND, including small sample sizes, invariability in study 
designs, non-representative samples, unequal control and treatment groups, the lack 
of objective measures for primary sleep variables, the lack of measurement of 
parental wellbeing and general child behaviour effects of treatment, and the lack of 
utilization of FBA as an assessment protocol and tool for informing intervention 
formulation.  
 
A considerable proportion of the studies found had a small sample size. 
Although single-case designs, which were a common study design utilized in the 
literature covered in this review, boost internal validity and allow for the clear 
demonstration of the functional relationship between treatment and outcomes, the 
generalizability or external validity of findings is concurrently restricted (Allen et al., 
2013; Didden et al., 1998; Piazza, Fisher, & Sherer, 1997; Weiskop et al., 2005). A 
small sample also decreases statistical power and simultaneously increases margin 
of error (Faber & Fonseca, 2014). Secondly, the few studies which do include larger 
sample sizes do not always describe the RGND participants in isolation 
(Montgomery, Stores, & Wiggs, 2004; Moss et al., 2014). The results of the few 
participants with RGND in these studies are considered within group means, making 
it difficult to draw conclusions specifically pertaining to RGND. Therefore, despite the 
good internal validity afforded by single-case studies, the research area would 
certainly benefit from future assessment of the effects of behavioural sleep 
interventions in larger populations and using different study designs, such as 
randomized controlled trials or experimental designs which incorporate multiple 
baselines, to provide a more rigorous test of treatment efficacy (Smith et al., 2007).  
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Further diminishing the external validity of the research described in this review 
is the limited representation of different RGND diagnoses. PWS (Didden et al., 
1998), FXS (Didden et al., 1998; Montgomery, Stores, & Wiggs, 2004; Weiskop et 
al., 2005), AS (Allen et al., 2013; Montgomery, Stores, & Wiggs, 2004; Moss et al., 
2014), and Williams syndrome (Montgomery, Stores, & Wiggs, 2004) are the only 
RGNDs included in the studies in this literature review. The lack of diversity in 
diagnoses restricts the extent to which research findings can be generalized to other 
RGNDs, of which there are many. This is especially the case with children with 
RGND, considering the uniqueness in the diagnostic/clinical features across different 
RGNDs. As such, the efficacy of behavioural sleep interventions with other RGNDs 
still requires investigation. 
 
Also, while not addressed by the authors in the article, Moss and colleagues’ 
(2014) study found significantly higher scores (in the ‘Clinically Significant’ range) in 
the wait-list control group at all data collection time points compared to the treatment 
group could suggest that it was not an equivalent point of comparison and therefore 
any conclusions drawn regarding between-group results may be disputable. There 
should have been no significant difference between groups at baseline, so that it 
could be accurately inferred that differences between the groups following treatment 
were attributable to one group receiving the intervention and the other not receiving 
intervention, and not some other extraneous variables (Bailey, 2008).  
 
Across half of the studies, there was an apparent reliance on parent report as 
opposed to more objective measures (Didden et al., 1998; Moss et al., 2014; 
Weiskop et al., 2005). While subjective, self-report measures have their value, they 
are subject to bias and therefore call into question the generalizability and certainty 
of results, especially when reliability data is not collected and analyzed, as was the 
case in these studies (Turner & Johnson, 2013). Future research needs to prioritize 
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the triangulation of multiple methods of assessment, including objective measures, in 
order to procure more credible results. 
 
There was only one study which included measures of parental wellbeing and 
general child behaviour variables prior to and following intervention (Moss et al., 
2014). These are important secondary treatment effects which future empirical 
research should investigate, as all behavioural interventions should endeavor to 
have a positive impact on the broader quality of life of the child and their family. By 
including measures of these variables in intervention studies, it may be ascertained 
whether the effect of treatment does in fact have further reaching repercussions for 
general child behaviour and parental wellbeing variables, or whether adjustments 
could be made to the intervention to maximize the benefit in this regard. 
 
FBA was similarly underused in past literature on the effectiveness of 
behavioural sleep interventions for children with RGND, with only two studies 
(Didden et al., 1998; Weiskop et al., 2005) reporting to have employed the 
assessment protocol. Both studies demonstrated the utility and benefits of 
conducting FBA to not only assess pre-treatment sleep difficulties and their related 
functions, but to inform the development of treatment plans for participants. Future 
research should heed the endorsement that these and other studies treating the 
sleep problems of children with developmental disabilities (Brown et al., 2013; 
Didden & Sigafoos, 2001; Hanley, 2016; Hanley et al., 2014; Kodak & Piazza, 2008) 
give to FBA and incorporate it into methodologies in order to enhance the empirical 
evidence-base for the procedure. 
 
All in all, while the existing literature presents promising findings which point to 
the potential efficacy of behaviourally-based sleep interventions for children with 
RGND, it is evident that more research is needed to properly gauge the effect of 
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The review presented in this chapter has highlighted the literature on the 
effectiveness of pharmacological and behaviourally-based sleep interventions used 
in the treatment of sleep problems in children with RGND as it currently stands. The 
studies that met the inclusion criteria have demonstrated positive sleep outcomes 
through the implementation of a small selection of medications, including melatonin 
(Braam et al., 2008; Gringas et al., 2017; McArthur et al., 1998; Miyamoto et al., 
1999; Zhdanova et al., 1999), human growth hormone (GH) replacement therapy 
(Itoh et al., 2004), and diphenhydramine HCI (Summers et al., 1992), antecedent-
based procedures, such as sleep hygiene modification (Allen et al., 2013; Didden et 
al., 1998; Montgomery, Stores, & Wiggs, 2004; Weiskop, Richdale, & Matthews, 
2005), establishing consistent sleep-wake times (Allen et al., 2013; Piazza et al., 
1997), and bedtime fading (Allen et al., 2013; Piazza et al., 1997). While generally 
positive treatment effects were found across the reviewed studies, the extant 
literature on the subject is minimal and suffers from a number of limitations. This, in 
conjunction with the high prevalence of sleep disturbance within this population, and 
the considerable direct and indirect consequences of such issues on the affected 
children and their families, provides abundant justification for the expansive 
investigation of the effectiveness of FBA-based behavioural interventions at treating 
the sleep disturbance of children with RGND. Given such, this study will add to the 
literature on this subject by investigating the effectiveness of FBA-informed, 
behaviourally-based interventions in the treatment of sleep disturbance amongst 
children with RGND, as well as examining any changes to child and parent wellbeing 
and quality of life following the sleep intervention. Additionally, this research will 
establish the treatment acceptability of the interventions implemented by parents 
with children with RGND experiencing sleep problems.  
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This study is guided by three research questions: 
 
1. Are FBA-based, behavioural sleep interventions effective in the treatment of 
sleep difficulties in children with RGND? 
2. Is parental wellbeing and general child behaviour effected by FBA-based, 
behavioural sleep interventions for children with RGND experiencing sleep 
disturbance? 
3. Are FBA-based, behavioural sleep interventions, and the assessment and 
treatment processes carried out as part of said treatment pursuit, acceptable 








The Sleep Research Team 
This investigation into the effectiveness of FBA-informed treatments for sleep 
disturbance in children with rare genetic neurodevelopmental disorders (RGND), is 
part of an expansive programme of research being undertaken by a team of 
researchers at the University of Canterbury. The wider research study endeavours to 
explore behaviourally based assessment and treatments for sleep problems in 
children with developmental disabilities. The wider research team is led by senior 
researchers and also includes a number of Masters and PhD students, intern and 
registered psychologists, and research assistants. 
Ethics and Participant Consent 
Ethical approval for this study was obtained from the University of Canterbury 
Human Ethics Committee (HEC 2018/48). Parents in this study provided written 
informed consent, and children provided assent, in alignment with their 
developmental level. Attached in Appendix A is a copy of the child’s information 
sheet and in Appendix B is the child assent form. Copies of the parent information 
sheet and the parent consent form are included in Appendices C and D respectively. 
Additional parental consent was provided for the video recording of children’s sleep. 
The child and parent audiovisual recording consent forms can be found in Appendix 
E and Appendix F. 
Design 
The current study followed a multiple-baseline-within-participants design. This 
type of research design allows researchers to examine individual participant’s 
intervention outcomes, as a measure of change from baseline. Single-case multiple 
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baseline designs also enable conclusions to be drawn from the replication of 
treatment effects across multiple participants. Given the distinctiveness of each 
child’s background, familial context, RGND diagnosis, and presenting sleep 
problems, and the need for individualization of treatment plans, a single-case 
multiple baseline research design was selected. When best practice procedures are 
adhered to, participants, inclusion/exclusion criteria, setting, dependent variables 
and their measurement, and independent variables are meticulously described in 
single-case research designs (Horner, Carr, Halle, McGee, Odom, & Wolery, 2005). 
Such thorough examination facilitates tight experimental control over extraneous 
variables and yields high internal validity (Cohen, Feinstein, Masuda, & Vowles, 
2014; Kratochwill et al., 2013; Sidman, 1960). A single-case research design also 
allows for flexibility with regard to modification to independent variables amid the 
study, such as altering components of a treatment. This is particularly useful in 
applied behavioural research (Cohen, Feinstein, Masuda, & Vowles, 2014). 
 
Data Analysis 
Graphs were created which represented the data collected over the baseline, 
intervention, and follow-up phases for each of the targeted dependent variables for 
each child. Dependent variables that were graphed included sleep onset latency 
(mins), frequency of night wakings, duration of night wakings (mins), and the 
percentage of total sleep time spent co-sleeping. Systematic visual analysis of the 
graphed dependent variables over the course of each study phase within cases, as 
well as across participants, constituted the main method of data analysis in this 
study. Recognition of visual analysis as being an effective method of assessing 
treatment effects/outcomes spans the field of experimental research, particularly in 
single-case multiple baseline across participant studies where the method is 
commonly employed (Blampied, 2013; Hanley et al., 2003). Within the current study, 
visual analysis made it possible determine whether or not change in behaviour over 
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time could be attributed to the intervention. Visual inspection of the mean, level, 
trend, variability, latency, and consistency of sleep-related behaviours were all 
factors that were examined (Cohen, Feinstein, Masuda, & Vowles, 2014).  
 
Analysis of pre- and post-treatment scores on all psychometrics, namely the 
CSHQ, VABS-II, DASS-21, PSQI, RQI, and CBCL, as well as the calculations of 
SPS scores, were compared within and between participants in order to ascertain 
whether any of the child or parent variables measured by the questionnaires 
changed as a consequence of intervention.  
 
Psychometrics completed by families at a single time-point, either at pre- or 
post-treatment (i.e., the QABF and TARF-R) were also examined. 
 
Participants 
Recruitment. Participants were recruited throughout New Zealand. Flyers 
providing information about the study were disseminated to relevant organisations 
and agencies that provide services for children with RGND and their families (e.g., 
the Angelman Network, Fragile X New Zealand Trust, and the Prader-Willi Syndrome 
Association of New Zealand). These organisations were asked to share study 
information across their networks, with those who may be interested. Study flyers 
invited participant self-referral or referral from relevant organizations or service 
providers.   
Screening and confidentiality. Potential participants were screened over the 
telephone, to determine whether they were eligible for inclusion in the study. Prior to 
asking screening questions, parents/caregivers were provided with a brief 
explanation of the purpose of the study and relevant procedures and matters related 
to confidentiality and anonymity were discussed. Parents were then asked a series 
	 66	
of questions to determine eligibility for inclusion in the study. The screening call took 
approximately 15 minutes. 
Inclusion/exclusion criteria. Children were deemed eligible to participate in this 
study provided that the following inclusion criteria were met: (a) they were between 
the ages of 2 and 18 years; (b) they had a diagnosis of a Rare Genetic 
Neurodevelopmental Disorder, as verified by a paediatrician, psychiatrist, registered 
psychologist, or other relevant medical professional; (c) they presented with parent-
reported sleep problems, including delayed sleep onset latency, bedtime resistance, 
frequent or prolonged night wakings, and/or unwanted co-sleeping. Children were 
excluded from the study if they had physical or medical comorbidities that may have 
compromised the effectiveness of treatment or that may have made it unsafe to 
implement intervention. Similarly, children were not included if it was established 
from the initial screening contact or clinical interview that the parents were unable or 
unwilling to adhere to the assessment or treatment processes.  
 
Participant characteristics. The participants included in this study were two 
boys and one girl ranging from 6 to 12 years of age. The children presented with a 
diverse array of RGND diagnoses, specifically FXS, PWS, and a child with various 
chromosomal deletions (details omitted given the rarity of the disorders and potential 
for identification of participants). Details such as individual ethnicity and actual 
names have not been reported, to ensure the protection of participants’ 
confidentiality and anonymity, and pseudonyms have been used in place of the 




Table 1. Summary of Participant Characteristics 
 
 
* = due to the rarity of Michael's chromosomal abnormality, the specific details of his diagnosis have been withheld to ensure that the 
participant is unable to be identified.
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Setting. As the participating families all lived outside of Christchurch, the clinical 
intake interviews and contact across study phases, was conducted via telephone or 
Skype™. Resources and equipment were delivered via post or email. The 
interventions were all implemented by the primary caregiver/s and extended family 
members of the children, and conducted in the family home.  Ongoing 
communication between members of the sleep team and the families was facilitated 
by phone, text, and/or email. 
 
Measures 
FBA measures. A combination of clinical interviews, analysis of video content 
and sleep diaries, and data from the Sleep Assessment Treatment Tool (SATT; Jin 
et al., 2013) and the Questions About Behavioural Function (QABF; Mason & 
Vollmer, 1995) were used to inform each child’s FBA.  Conclusions drawn from the 
FBA aided in the development of comprehensive treatment plans tailored to each 
individual child.  
 
Sleep Assessment Treatment Tool (SATT; Jin et al., 2013). Data from the 
clinical interview pertaining to the child’s sleep was used to complete the SATT. The 
SATT enabled sleep problems and parent goals to be clearly identified and defined, 
for the purpose of guiding the FBA. The SATT includes questions aimed to assess: 
a) the history of the presenting sleep problems; b) parents sleep-related treatment 
goals;  c) the specific sleep problems, including bedtime routine resistance, sleep 
onset delay, sleep interfering behaviour, co-sleeping, night wakings, and early 
wakings; d) any antecedents or consequences occurring before or after the 
behaviour that parents can identify; e) the sleep schedule currently in place for the 
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child; f) the child’s routine leading to eventual sleep onset; g) the child’s sleep 
environment; and h) any sleep dependencies.  
 
Questions About Behavioural Function (QABF; Mason & Vollmer, 1995). The 
QABF is a 25-item psychometric that aids in hypothesizing about the function of 
target behaviour (Freeman, Walker, & Kaufman, 2007; Healy, Brett, & Leader, 2013; 
Paclawskyj, Matson, Rush, Smalls, & Vollmer, 2000). The QABF comprises five 
subscales: Social Attention, Escape, Non-social Reinforcement, Physical Discomfort, 
and Tangible Reinforcement. Each subscale contains five items, which are scored 
on a four-point scale, indicating the frequency with which each item is applicable: 
Doesn’t apply (Never), 1 (Rarely), 2 (Some), or 3 (Often). Subscale scores and their 
corresponding severity ratings are calculated separately.  
 
The QABF is a standard measurement component of functional behavioural 
assessment, and has the strongest psychometric properties of all functional 
assessment scales currently (Matson, Tureck, & Rieske, 2012). The QABF has good 
test-retest reliability ranging between 0.81 to 0.82, moderate to good interrater 
reliability from 0.63 to 0.68, and good internal consistency across the five subscales, 
ranging from 0.89 to 0.96 (Freeman et al., 2007; Healy et al., 2013; Matson et al., 
2012; Paclawskyj et al., 2000; Zaja et al., 2011). 
 
The QABF was completed by one parent during baseline, focusing on a 
specified target behaviour. 
 
Primary sleep measures.  
 
Video recordings. Night-time video recordings were made using either a 
Swann-Advanced-Series DVR4-1200 camera, or a D-Link HD Cloud Camera. All 
cameras were infrared and had the capacity to record multiple nights. A monitor was 
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included in the DVR4 package, and connecting this to the camera made it possible 
for parents to check live footage.  Parents were instructed to situate the video 
camera so that it was inconspicuous to the child, and so that it gave a clear and 
unobstructed view of the child and their bed. Video recordings made by the DVR4 
camera were stored in an internal hard drive, and a micro SD card for the DSLR 
cameras. Families were provided with a set of written instructions with corresponding 
photographs to guide the set-up of the video equipment. Those families that received 
a DVR4 camera were told to turn the camera on just before they bid their child 
goodnight and to turn off the camera when their child woke for the day the following 
morning. The D-Link cameras were preset to record from half an hour before the 
child’s specified bedtime to one hour after their anticipated morning wake time. The 
video data was intended to supplement the subjective measures used throughout 
study phases, such as sleep diaries. Video recordings allow the child’s behavior and 
sleep-wake phases to be coded objectively, by an independent observer in order to 
fill in any information not reported in the diaries and to collect interobserver 
agreement data.  Video recordings were obtained for a minimum of 30% of nights.  
 
Sleep diaries. Sleep diaries are a popular tool for examining children’s sleep 
(Blampied, 2013; France & Blampied, 2005; McLay & France, 2016). The diaries 
were formatted with columns designated for each day of the week, which were 
intersected by rows that allowed for parents to report such dependent variables as 
day-time sleep (including the setting, time asleep, and time awake), night-time sleep 
(including setting, time put to bed, frequency of curtain calls, nature of curtain calls, 
parental responses to curtain calls, and estimated time of sleep initiation). On a 
second attached sheet, and in a continuation of the same format, rows provided 
space for parents to note down two night wakings, each including cells for 
description of the time and duration of the waking, the child’s behaviour while awake, 
and the parents’ responses. Then lastly, a row was included for the reporting of 
morning wake time. All requests for the duration of wakings were in the unit of 
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minutes. At the end of the two-page document was a definition of curtain calls for the 
parents’ reference, and space for any additional notes. Parents could fill in the sleep 
diaries by writing a description of behaviours. An example of a sleep diary used by 
families participating in the study is attached in Appendix G. Parents were asked to 
complete sleep diaries each night across study phases.  Collection of sleep diaries 
during the assessment phase helped to ensure that the families understood how to 
complete the diaries accurately, while also providing valuable information that would 
be used to develop the child’s treatment plan.  Over the course of the intervention 
phase, the researcher and/or psychologist would maintain regular contact with the 
families to collect the latest sleep diaries. The frequent sharing of sleep diary data 
ensured that the sleep team had up to date information regarding the children’s 
progress, and were therefore able to promptly react to the children’s responses to 
intervention, and adjust the intervention plan when necessary. Sleep diary data was 
graphed and analyzed visually for the purposes of assessment and the monitoring of 
progress. 
 The researcher provided the families with sleep diaries either in printed form or 
as an electronic copy shared over email, and explained to the parents how to fill in 
the necessary information.  
Sleep Problem Severity Score. A score was calculated which summarized the 
severity of the children’s total sleep disturbance at each measurement time-point in 
the study, in emulation of the methodology carried out by Lawton, France, and 
Blampied (1991). For each sleep variable, a score of 1 is given if there was an 
occurrence of that sleep problem to any extent during the night (i.e., co‐sleeping at 
sleep onset = 1; co‐ sleeping following NW = 1; SOL > 15 min = 1; and no NW = 0), 
and conversely if a feature of sleep disturbance was not present, a score of 0 would 
be given. The scoring of the duration of NW however followed a different method, 
with total NW duration < 5 min receiving a score of 1; or total NW duration > 5 min 
receiving a score of 2. The maximum possible score per night was 5. All of the total 
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nightly scores over the course of each study phase were summed to give an SPS 
score for baseline, intervention, and follow-up (Lawton, France, & Blampied, 1991). 
 
The Children’s Sleep Habits Questionnaire (CSHQ; Owens, Spirito, & 
McGuinn, 2000). The CSHQ is a 45-item parent-report measure that is used to 
identify sleep problems such as bedtime resistance, sleep onset delay, sleep 
duration and night waking (Owens et al., 2000). One parent was instructed to 
complete the CSHQ at assessment and again during maintenance in the current 
study. The CSHQ constitutes eight subscales which target specific sleep-related 
problems. These subscales include Bedtime Resistance, Sleep Onset Delay, Sleep 
Duration, Sleep Anxiety, Night Wakings, Parasomnias, Sleep Disordered Breathing, 
and Daytime Sleepiness.  Parents indicate the frequency of various sleep behaviours 
exhibited by their child over the past week on a three-point scale - ‘usually’ (5-7 
nights per week), ‘sometimes’ (2-4 nights per week), or ‘rarely’ (0-1 night per week). 
The questionnaire also asks parents to specify whether each of their child’s sleep 
behaviours are problematic for the family. The eight scores derived from each 
subscale are added together to obtain a total sleep disturbance score.  
 
The CSHQ has been administered extensively in sleep research involving 
typically developing children (Krakowiak et al., 2008; Markovich, Gendron, & 
Corkum, 2015), and children with neurodevelopmental disorders such as ASD 
(Lambert et al., 2016; May et al., 2015; Mazuerk & Sohl, 2016). The CSHQ is widely 
used in clinical practice and research and has acceptable psychometric properties 
(Hodge, Parnell, Hoffman, & Sweeney, 2012; Hoffman, Sweeney, Gilliam, & Lopez-
Wagner, 2006). The questionnaire has a sufficient internal consistency in a clinical 
sample (α=.78), as well as a community sample (α=.68) (Owens et al., 2000). The 
CSHQ also has adequate test-retest reliability (ranging from .62-.79) (Owens et al., 
2000). On the matter of validity, the CSHQ is capable of differentiating between 
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clinical and control groups, where sensitivity was 0.80 and specificity was 0.72 
(Owens et al., 2000).  
 
The CSHQ was administered during baseline, and upon completion of 
treatment. The repeated measurement allowed for the assessment of change in 
dependent variables.   
 
The outcome of the measures discussed in the above section informed the 
development of children’s individualized treatment plans. 
 
Measures of parental sleep, well-being, and relationship satisfaction. In the 
current study, the DASS-21, RQI, and PSQI were administered to all primary 
caregivers of participating children during assessment and maintenance to assess 
any change in levels of parental depression, anxiety or stress, perceptions of 
parental relationship quality, and parent sleep quality, following the intervention. 
 
Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, Berman, & 
Kupfer, 1989). The PSQI is a self-report measure of sleep quality in adults containing 
18 items targeting the frequency with which certain sleep behaviours occur, as well 
as sleep quality, sleep onset, sleep efficiency, sleep disturbance, sleep medication, 
and daytime sleepiness (Buysse et al., 1989). In the current study, the PSQI was 
administered during assessment and maintenance to all primary caregivers. Four 
items are posed in question-form and respondents are instructed to answer them in 
reference to their sleep over the past month. 13 items relate to the frequency of 
sleep behaviours and are rated on a four point Likert scale ranging from 0 (not during 
the past month), 1 (less than once a week), 2 (once or twice a week), or 3 (three or 
more times a week). The final item asks for a rating of the respondent’s overall sleep 
quality and is rated as either 0 (very good), 1 (fairly good), 2 (fairly bad), or 3 (very 
bad). A global score is determined by adding seven component scores together. 
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Reports of satisfactory psychometric properties have been made, including an 
internal reliability of .83, and a test-retest reliability of 0.85 (Buysse et al, 1989). The 
PSQI is frequently use in both clinical and research settings to measure the sleep 
quality of parents and children, typically developing or with developmental disabilities 
such as ASD (Carpenter & Andrykowski, 1998; Giallo, Wood, Jellet, & Porter, 2011; 
Hodge et al., 2013; Hoffman et al., 2008; Lopez-Wagner et al., 2008; McBean, 
Schlosnagle, 2016; Meltzer, 2008). 
 
The Depression Anxiety and Stress Scales (DASS-21; Lovibond & Lovibond, 
1995). The DASS-21 is a self-report measure containing 21-items relating to 
symptoms of depression, anxiety, and stress (Henry & Crawford, 2005). All primary 
caregivers in the current study completed the DASS-21 during assessment and 
maintenance phases. The DASS-21 requires the informant to note the extent to 
which the various statements were relevant for them over the past week. 
Respondents rate each … on a four-point scale – ‘0’ (did not apply to me at all), ‘1’ 
(applied to me to some degree, or some of the time), ‘2’ (applied to me a substantial 
amount of the time), and ‘3’ (applied to me most of the time). In scoring the DASS-
21, severity levels for the depression, anxiety, and stress axes may be determined, 
and severity labels of “normal’, ‘mild’, ‘moderate’, ‘severe’, or ‘extreme’ are provided.  
 
The DASS-21 has demonstrated good psychometric properties, particularly 
with respect to reliability (α=.82- .90 for the subscales), internal consistency (ranging 
from 0.87 to 0.94 across subscales) (Antony, Bieling, Cox, Enns, & Swinson, 1998), 
and convergent and discriminative validity (Henry & Crawford, 2005). Use of the 
DASS-21 has been widely used with adult populations in clinical and research 
contexts, and with samples of parents of children with neurodevelopmental disorders 
such as ASD (Al-Farsi, Al-Farsi, Al Sharbati, & Al-adawi, 2016; Giallo et al., 2011).  
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Relationship Quality Index (RQI; Norton, 1983). The RQI is a tool that is a 6-
item measure of a couple’s perceptions of their satisfaction with their relationship, as 
well as their perception of the quality of their relationship (Sanders, Markie-Dadds, & 
Turner, 2001). For two of the participants in the current study, the RQI was 
administered to both of their parents during assessment, and then again during 
maintenance. Participants rate the degree to which they are in agreement with 
various statements concerning their partner and relationship. Ratings are given on a 
7-point Likert scale (1 = very strongly disagree through to 7 = very strongly agree). 
Global relationship satisfaction is ascertained through the summing of scores, with 
higher scores denoting higher satisfaction. 
 
Adequate psychometric properties have been established for the RQI, including 
an interrater reliability of .70, and internal consistency ranging from .25 to .65, which 
researchers have contended illustrates the RQI’s ability to measure elements of 
relationship quality that are simultaneously related and yet distinct (Lawrence, Brock, 
Barry et al., 2008). 
 
Measures of General Child Behaviour. The VABS-II and the CBCL were 
administered by an intern psychologist or researcher at the baseline and 
maintenance phases of the study to provide an impression of potential secondary 
effects of treatment. 
 
The Vineland Adaptive Behaviour Scales-II, Parent/Caregiver Rating Form 
(VABS-II; Sparrow, Cicchetti & Balla, 2005). The VABS-II measures a child’s 
adaptive functioning, including their level of proficiency at navigating social contexts 
and functioning within their everyday environment (Gleason & Coster, 2012; Sparrow 
et al., 2005; Tassé et al., 2012). The the Communication Domain segment of the 
VABS-II was completed at pre- and post-intervention by one parent. It was used to 
measure the participants’ receptive and expressive communication abilities prior to 
	 76	
and following intervention for their sleep problems. The VABS-II is a parent/caregiver 
report form for individuals between 0 to 90 years of age. Parents were instructed to 
select the option that best describes the frequency with which their child engages in 
certain behaviours using a three-point scale, where ‘usually’ is coded as ‘2’, 
‘sometimes or partially’ is coded as ‘1’, and ‘never’ is coded as ‘0’. The questionnaire 
also provides a ‘don’t know’ option in instances where the parent or caregiver is 
unsure of the frequency of a particular behaviour.  
 
The VABS-II has been used extensively in research and clinical practice, and 
consequently has acquired a considerable amount of normative data (Achenbach & 
Rescoria, 2001; Tassé et al., 2012). Good psychometric properties have been found 
for the VABS-II, including an internal consistency of .93 to .97 across age groups, 
and a test-retest reliability of ranging between .76 and .92 across the five domains 
(Sparrow, Cicchetti, & Balla, 2005). There has been ample utilization of the VABS-II 
in populations of children and adolescents with intellectual disabilities, independence 
issues, and developmental disabilities, including autism (Gabriels et al., 2005; 
Gleason & Coster, 2012; Sikora et al., 2012; Tassé et al., 2012). The measure has 
shown good reliability in being able to differentiate clinical and non-clinical samples, 
with clinical groups reliably producing an adaptive behaviour composite score 
approximately two standard deviations below the non-clinical mean, whilst still 
generating distinct profiles across different clinical groups (Sparrow, Cicchetti, & 
Balla, 2005).      
 
Child Behavior Checklist (1 ½ - 5 years) and (6 – 18 years) (CBCL (1 ½ -5), 
Achenbach & Rescorla, 2000; CBCL (6-18), Achenbach & Rescoria, 2001). The 
CBCL (1 ½ - 5) is a standardized measure based on parent report that includes 100-
items assessing internalizing and externalizing behaviours in preschoolers aged 
between 18 months and 5 years. For older children (6 to 18 years), the school-age 
form of the CBCL is administered to either parents, or teachers.  Parents noted the 
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frequency of behaviours on a three-point Likert scale: 0 (not true), 1 (somewhat or 
sometimes true), or 2 (very true or often true). Across the seven syndrome scales 
(emotionally reactive, anxious/depressed, somatic complaints, withdrawn, sleep 
problems, attention problems, and aggressive behaviour) and five scales associated 
with DSM-5 diagnoses (depression, anxiety, ASD, ADHD, and oppositional 
defiance), scores are added up and converted into T scores. T scores from the 
various scales are combined to provide internalizing problems, externalizing 
problems and total problems composite scores, which indicate problem severity as 
falling within normal, borderline, or clinical ranges. 
 
Adequate reliability and validity have been demonstrated with the CBCL. An 
internal consistency of .63 to .97 across scales has been found (Tehrani-Doost, 
Shahrivar, Pakbaz, Rezaie, & Ahmadi, 2011), test re-test reliability ranging from .80 
to .94 (Achenbach & Rescoria, 2001), and good convergent and divergent validity 
(Nakamura, Ebesutani, Bernstein, & Chorpita, 2008). The CBCL has been commonly 
used in the assessment of sleep problems in populations with ASD (Anders, Iosig, 
Schwichtenberg, Tang, & Goodlin-Jones, 2012; Delahaye et al., 2014; Fadini et al., 
2015; Goldman et al., 2009; Hollway, Aman, & Butter, 2013; Lambert et al., 2016; 
Moon et al., 2011; Sikora, Johnson, Clemons, & Katz, 2012).  
 
Treatment acceptability measures. 
Treatment Acceptability Rating Form – Revised (TARF-R; Reimers & Wacker, 
1992). The TARF-R is a brief 20-item questionnaire used to measure treatment 
acceptability ratings (Reimers & Wacker, 1992). In the current study, parents 
completed the TARF-R during the maintenance phase. For 17 of the items, parents 
were asked to rate their perception of how appropriate, fair, and effective the 
intervention was.  Parents’ perception of the severity of their child’s present 
behaviour and parents’ understanding of the intervention procedures was assessed 
in the remaining three items. The 20 items of the TARF-R were rated using a 7-point 
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Likert scale. The questionnaire produces scores that are added to give a total 
acceptability score.  
 
The TARF-R has been shown to have good reliability (α=.92) and clinical utility 
(Finn & Sladeczek, 2001; Reimers & Wacker, 1992). The measure of treatment 
acceptability has been used in studies examining the effectiveness of treatments for 
challenging behaviours in many different populations, including children with autism 
(Lee, Anderson, & Moore, 2014; McLay, Carnett, van der Meer, & Lang, 2015).  
The TARF-R and post-treatment interview were completed during the maintenance 
phase. 
 
Post-treatment interview. On conclusion of intervention, a semi-structured 
interview was undertaken by a member of the research team who had not had any 
previous contact with the the family. During this interview parents were asked about 
their experience with the assessment and treatment process, the degree to which 
they were satisfied/dissatisfied with the treatment outcomes and their thoughts on 
how the treatment process could have been improved.  
Dependent Variables 
The type and topography of the sleep problems and parents’ treatment goals 
were used to determine the dependent variables measured for each child.  
Dependent variables were recorded from the beginning of the bedtime routine to the 
time that the child woke for the day. Common dependent variables are defined in the 
following paragraphs. 
 
Awake. To be considered awake, a child would have to exhibit open eyes, 
and/or some form of sleep-interfering behaviour (as defined below), vocalization, or 
excessive bodily movements that would suggest a wakeful state.   
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Asleep. To be deemed asleep, a child would need to be lying in bed with closed 
eyes, and not voluntarily moving about or vocalizing. Movements that were 
characteristic of REM sleep were differentiated from wakeful movements.  
 
Co-sleeping. A child would be reported to have engaged in co-sleeping if they 
lay in the same bed with another person for any length of time during the night. This 
included the sleep onset period as well as co-sleeping in response to a night waking. 
Co-sleeping may have been initiated by the child or parent. Co-sleeping was 
determined by calculating the percentage of total sleep time that was spent sleeping 
with a parent. 
 
Parental presence. Parental presence included any occasion in which a parent 
was in physical or visual vicinity of the child during the onset of sleep (e.g., sitting in 
a chair beside the bed). This dichotomized as a presence or absence of a parent.      
 
Sleep-interfering behavior. Sleep-interfering behaviour encompassed any 
behaviours that occurred upon being bid goodnight that interfered with the with the 
child’s ability to establish the behavioural quietude needed to initiate sleep. For 
example, vocalising (e.g., talking, screaming, crying, calling out, singing, humming, 
or laughing), physical actions (e.g., sitting, standing, getting out of bed, playing with 
objects) and stereotypic behaviours (e.g., repetitive movements).  
 
Sleep onset latency. Sleep onset latency was defined as the amount of time in 
minutes, that elapsed between the child being bid goodnight, and the onset of sleep.  
 
Night waking. A night waking was defined as an arousal that occurred following 
initial sleep onset that interrupted a period of sleep that lasts longer than 2 minutes.  
Any waking that took place before the child’s agreed morning wake time and/or that 
was prior to 6am was classified as a night waking. The frequency and duration (in 
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minutes) of a night waking was recorded in sleep diaries. The duration of a night 
waking was calculated by adding up the time spent awake during every NW that 
occurs over the course of an evening. 
 
Curtain calls. Curtain calls were defined as behaviours that occurred during the 
initial sleep onset period, which served the purpose of obtaining parental attention 
(e.g., calling for a parent to enter their bedroom, leaving their bedroom). The child 
may have remained in bed or left their bed/bedroom in order to access parental 
attention or preferred items. The frequency of curtain calls was recorded in sleep 
diaries. 
Procedure/Study Phases 
Participants and their families persevered through each phase of the study, 
beginning with an initial assessment, followed by baseline, intervention, 
maintenance, and short-term follow-up phases.  
 
Assessment. The assessment phase included a clinical interview undertaken 
by a registered intern psychologist.  The open-ended clinical interview followed the 
structure of the standard intake interview used at the Pukemanu Dovedale Centre 
Clinic at the University of Canterbury. The clinical interview sought to obtain details 
concerning any previous attempts made to improve sleep, medical or physical 
conditions that may contribute toward the child’s sleep problems, the child’s RGND 
diagnosis, and other relevant contextual information about the child’s life and family. 
On conclusion of the clinical interview, parents were given the opportunity to ask any 
questions that they had.  The interviews were conducted via phone call or Skype. 
The clinical interviews were usually 1 ½ hours in length, with flexibility to suit the 
time-restraints of the families, as well as the variable duration of the open-ended 
dialogue. Examples of questions used in the clinical interview are included in 
Appendix H. The assessment phase also included the administration of the FBA 
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measures, sleep outcome measures, and measures of children’s general behaviour 
and daytime functioning. Also completed during the assessment phase were a 
selection of parental sleep quality, parent well-being, and relationship quality 
measures. Data gathered during the clinical interview was used to aid in the 
formulation of individualised treatment plans. 
 
Baseline. Sleep patterns and sleep-related behaviours were established during 
the baseline phase using a combination of daily sleep diaries and video footage. 
Parents were instructed to record daily sleep diaries along with video during their 
child’s assigned baseline period. Children were randomly assigned to a baseline 
period of one, two or three weeks. The baseline start date was arranged so that it 
would be followed immediately by the commencement of intervention. During 
baseline, parents were asked not to make any alteration to their child’s sleep 
schedule, bedtime routine, or their responses to their child’s sleep-related behaviour. 
This stipulation was put in place to ensure that any change in the dependent 
variables that were observed following the commencement of intervention could be 
attributed to the intervention procedures, rather than variations in the environmental 
context or parents’ behaviour. 
 
Intervention. Intervention began immediately following the end of their assigned 
baseline period. Each family was provided with an individually-tailored, multi-
component intervention plan which was informed by the outcomes of the FBA. The 
general goal across the participating families was to increase sleep conducive 
behaviours, and decrease sleep interfering or sleep incompatible behaviours. During 
the preceding baseline phase, families were provided with a proposed treatment 
plan, which described the particular intervention methods and instructions for their 
implementation. Families had the opportunity to comment on the drafted plan and 
offer any input before the final intervention plan was put into effect. Once the 
intervention plan was agreed upon by all parties, families were provided with the 
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resources necessary to carry out their child’s intervention (e.g., social stories, 
Groclock). 
 
Throughout the intervention phase, frequent contact was maintained between 
the researcher or psychologist and the family, via phone calls or emails. During the 
early stages of intervention, daily contact was maintained with the families. Sleep 
diaries were also received on a weekly basis, which permitted the allowed for close 
monitoring of progress and any problems that may have been encountered during 
intervention. If necessary, this made it possible to amend the intervention plan in a 
timely manner. Ongoing communication between the families and the research team 
also allowed for encouragement and emotional support to be offered to the parents. 
It was thought that this would bolster their sense of self-efficacy and competence, in 
turn increasing the likelihood of treatment adherence and desired treatment 
outcomes (Sanders & Burke, 2014). 
 
Interventions were implemented until the sleep problem had been resolved, the 
family and/or the researchers were content with the level of improvement in sleep-
related dependent variables, or until the parents decided to withdraw from the study.  
At this point, the family moved into the maintenance phase.  
 
Common treatment components. There were a number of common treatment 
components across participants. This included social stories, use of visual aids as 
discriminative stimuli to facilitate the understanding of appropriate sleep and wake 
times, modification to sleep/wake schedules, faded bedtime, and rewards.  
 
Social story. Each of the children participating in the study were provided with 
an individually-designed social story to use during intervention. Social stories 
generally depicted the steps in the bedtime routine, any changes in sleep setting, 
changes in expectations/goals, visual supports to be used, and reinforcement 
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contingencies. Parents provided the images but the social stories were constructed 
by the researcher. As is recommended by Gray (2010), the written text that 
accompanied the photographs was kept very brief, developmentally-appropriate, and 
was written in the first-person. These guidelines aim to hold the attention of the child 
and facilitate comprehension (Gray, 2010). Social stories are read with the child 
each night to help them to acclimate to their new sleep routine and any rules 
regarding their night-time behaviour by providing information relating to any who, 
what, where, and why questions that the child might have (Gray & Garand, 1993). 
The stories were presented in the form of a laminated and bound booklet containing 
photographs and accompanying text representing and describing each step in the 
child’s bedtime routine, how they are advised to behave during night wakings, and 
any rewards that would follow the successful completion of this routine. The 
photographs showed the child him or her-self modelling the various steps in their 
routine, as well as images of any relevant sleep settings or items. The text was 
worded in a first-person, present tense narrative, and framed in a positive and 
empowering manner. The social stories were made to be concise, only including and 
describing steps that were necessary, as well as developmentally-appropriate for the 
individual child.  
 
Discriminative stimuli for sleep and wake time.  Visual aids and Groclocks were 
used with the children as prompts to help them learn to differentiate appropriate 
sleep and wake times. Two of the three children’s intervention plans involved a 
Groclock. A Groclock has a screen which changes at preset times, showing a sun 
when it is time to wake up and a star when it is time to sleep. Groclocks provide a 
discriminative stimulus for the child to support them to distinguish between sleep and 
wake time. In the instance of bedtime resistance, a night waking, or early morning 
waking, parents could direct their child’s attention to the Groclock and explain to 
them that they can “get up when the sun comes up”, or point to their visual aid (in the 
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case of the other participant), which displays a sun, and explain that they are not to 
get up for the day until their surroundings resembled those shown in the visual aid. 
 
Establishing a consistent sleep/wake schedule. A consistent sleep schedule 
was established through the enforcement of consistent sleep and wake times, and 
the elimination of daytime naps. These methods were implemented for all three 
children and served to establish a consistent sleep pattern by instigating a fixed 
duration of sleep. Parents were instructed to put their child to bed at specified times, 
and similarly wake them up at certain times in the morning. With regard to the 
prevention of sleep during the day, this was prescribed so that sleep pressure could 
be built in the lead up to bed time, as well as to facilitate good sleep hygiene 
practices at night time. The children were provided with preferred alternative 
activities to promote wakefulness in these instances, such as snacks and games. 
 
Faded bedtime.  Faded bedtimes were used with all three of the participating 
children and involved the shifting of a child’s pre-intervention bedtime to a later time. 
The goal with this treatment method is to decrease sleep onset latency, with the child 
initiating sleep shortly after being bid goodnight by their parent. By delaying the 
child’s bedtime, their need for sleep is increased and in turn so is the likelihood of 
them falling asleep quickly. The exact time of the delayed bedtime was established 
as being within 15 minutes of the time that the child typically fell asleep during 
baseline. Over the course of the intervention phase, faded bedtimes were at times 
shifted earlier or later, to promote progress in the reduction of sleep onset latency. 
 
Rewards. While recommended for use with all three children, only 2/3 parents 
implemented a reward system with their child. Parents provided rewards in the form 
or verbal praise and/or a preferred tangible reward (for example; food, stickers, or an 
enjoyable activity), contingent upon their child’s demonstration of target behaviours, 
such as staying in their own bed the whole evening. In both cases these rewards 
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were given in the morning and tangible rewards were provided by and at the cost of 
the parents. 
 
Maintenance. During the maintenance phase, the parents and researchers had 
no contact. This break in communication was necessary for families to fully embed 
new sleep-conducive behaviours into their everyday lives and allow for progress to 
generalize outside of the context of treatment (Blampied, 2013; Sanders & Burke, 
2014). Parents completed post-treatment psychometrics and a post-treatment 
interview during this phase.  
 
Short-term follow-up. At roughly four weeks post-treatment, families were 
asked to record seven nights of video footage and sleep diaries.   The data gathered 




A summary of the participant’s sleep problems as reported by their parents, the 
precipitating and/or maintaining factors identified through FBA, the hypothesized 
function of the sleep problems, and the selected interventions for each of the three 
children is presented in Table 2. 
 
Hannah. 
Family’s goals for treatment. The parents’ goals included:  1) for Hannah to take 
herself back to her own bed after waking to use the toilet and for her to remain there 
for the duration of the night; 2) for Hannah to settle herself back to sleep independently 
upon waking in the night; 3) for Hannah to learn to settle herself independently (i.e., 
without parental presence in the bedroom) during sleep onset; 4) for Hannah to wake 
after a more appropriate time of 6am in the morning. 
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FBA outcomes. Hannah’s FBA indicated that multiple factors may be responsible 
for the maintenance of her sleep difficulties. The functions behind Hannah’s difficulty 
self-settling following night wakings and subsequent co-sleeping were established as 
being a desire for parental attention, in the form of conversation, as well as a desire 
for physical contact. The enabling of co-sleeping by Hannah’s parents provided such 
positive reinforcement and henceforth cemented these sleep problems. Hannah’s 
early morning wakings and disruptive behaviour in the morning were found to be 
similarly maintained by the social reinforcement of parental attention. Additionally, 
having access to preferred items (e.g., toys in the lounge) and the opportunity to roam 
the house and property unsupervised were identified as functions of these undesired 
sleep-related behaviours.  
 
Method. 
Baseline (BL). Hannah’s family carried out baseline phase with a randomly 
assigned duration of one week.  
 
Intervention. The treatment plan designed for Hannah included faded bedtime, 
sleep/wake scheduling, elimination of daytime naps, discriminative stimulus for 
sleep/wake time, a social story, removal of parental presence, and reinforcement. Any 
variation on the common intervention components described on pages 77 to 79 is 
outlined below. 
 
Faded bedtime. Hannah’s bedtime was shifted from 7.30 to 8.30pm. In this case, 
even though Hannah’s sleep onset latency was not deemed problematic at 
assessment, it was hypothesized that increase in the biological need for sleep may 
result in a reduction in the frequency of night wakings and early morning waking, which 
were indicated as being problematic.  
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Sleep/wake scheduling. Hannah’s parents were asked to ensure that Hannah 
was awake for the day by 6.30am. 
 
Reward system. Hannah was provided with a tangible reward, paired with praise 
and social attention, contingent upon her compliance with intervention, namely staying 
in her own bed for the entire evening.  
 




Family’s goals for treatment. Robert’s parents’ goals for intervention were to: 1) 
fall asleep independently in his own bed, without exhibiting signs of distress, and 
remain there for the whole night, and 2) resettle himself independently following a night 
waking.  
 
FBA outcomes. Results from the FBA indicated that Robert’s sleep onset delay 
and difficulty independently initiating sleep, inability to resettle himself following night 
wakings, and co-sleeping were likely maintained by social reinforcement. It is clear 
that Robert was seeking out parental attention, given that he would follow them around 
during the night upon waking. In receiving this desired attention from his parents, his 
behaviour was henceforth reinforced. With respect to Robert’s early morning wakings, 
his FBA revealed that access to preferred activities and tangible items, such as 
television and toys, was a maintaining factor.  
 
Method. 




Intervention. Interventions strategies implemented included a faded bedtime, 
consistent sleep/wake scheduling, discriminative stimulus for sleep/wake time, a 
social story, and removal of parental presence.  
 
Faded bedtime and consistent morning wake-time. Robert’s bedtime was 
changed from 7.00pm until 8.30pm. His parents were also asked to enforce a 
consistent wake time of 6.30am each day. 
 
Discriminative stimulus for sleep/wake time. Robert’s parents were asked to 
turn the Groclock on when Robert was put to bed at 8.30pm (initially), and set to 
display the sun at 6.30am when he was able to get up for the day.  
 
No procedural modifications were made to Robert’s treatment plan. 
 
Michael. 
Family’s goals for treatment. The family’s goals for treatment were 1) for 
Michael to remain in his own bed for the entire night and subsequently eliminate co-
sleeping; 2) for Michael to be able to independently resume sleep following night 
wakings; 3) to reduce sleep onset duration; 4) increase compliance with the bedtime 
routine; and 5) eliminate curtain calls.  
 
FBA outcomes. The results of Michael’s FBA suggested that his sleep problems 
were being maintained by multiple potential factors. The positive reinforcement that 
Michael gained from his maternal attention and physical contact through co-sleeping 
was a possible factor that was strengthening his undesired curtain calls, night wakings, 
and inability to self-settle. In summation, Michael’s sleep problems were determined 




Baseline (BL). Michael was randomly assigned a three-week baseline phase. 
 
Intervention. Treatment recommendations included a social story, discriminative 
stimulus for sleep/wake time, extinction, elimination of daytime naps, and a reward 
system.  
 
Faded bedtime. Michael’s bedtime was delayed from 8.30pm to 9.00pm. 
 
Discriminative stimulus for sleep/wake time. The visual aid displayed a 
photograph of his clock with hands showing 7 o’clock in the morning. There is also text 
underneath the photograph saying ‘Morning Time’ along with a cartoon image of a 
sun. The visual aid was situated on the wall of his bedroom and was used to model 
the time of day that Michael was able to get up and go and see his mother.  
 
Extinction.  If Michael left his bed after being bid goodnight, his mother was 
instructed to return him to bed, say “goodnight,” and then leave the room. She was to 
do this with minimal communication and in a calm manner. His mother also reminded 
him that he was to remain in his bed until his clock matched his visual aid (7:00am) or 
when she comes to wake him in the morning. In cases where Michael’s mother was 
concerned for his health or safety, she was to check on him with as minimal attention 
as was necessary. 
 
Reward system/reinforcement procedure. A reward system was put in place 
where Michael received tokens for falling asleep in his bed independently and for 
staying in his bed all night.   These were later exchanged for tangible rewards.  
 
Procedural modifications.  On night 58 of intervention, a further delay to Michael’s 
bedtime was instituted in an attempt to further reduce his sleep onset latency. His 
bedtime was delayed until 9.15pm to 9.30pm.  
Table 2. Parent reported sleep problem/s, precipitating and/or maintaining factors, hypothesized function, and intervention for 
each of the three children 
Child 





Hypothesized function Intervention 
Hannah 
Night wakings, co-sleeping, 
early morning waking, day-
time napping 
Parental attention, preferred 
activities (i.e., exploring 
house) and tangible items 
(i.e., toys) 
Attention, escape from 
bed 
Social story, Groclock, faded 
bedtime, sleep/wake scheduling, 
removal of parental presence, 
reward system, elimination of 
daytime naps 
Michael 
Bedtime resistance, sleep 
onset delay, night wakings, 
co-sleeping, day-time 
napping 




Social story, visual aid, faded 
bedtime, extinction, rewards system, 
elimination of daytime naps 
Robert 
Sleep onset delay, night 
wakings, co-sleeping, early 
morning waking  
Parental attention, preferred 
activities (i.e., television) and 
tangible items (i.e., toys) 
Attention, escape from 
bed 
Social story, Groclock, faded 
bedtime, sleep/wake scheduling, 





Chapter 5 presents data on sleep outcomes following sleep intervention for 
each of the three participants. Data relating to parental sleep quality and well-being, 
children’s daytime behaviour and communication at pre- and post-intervention is also 
presented. Finally, treatment acceptability data gathered post-intervention is also 
reported. 
 
Although she completed intervention, follow-up data for Hannah had not been 
collected at the time of submission of the current study. Data from Hannah’s baseline 
and intervention phases alone, is presented in the results.  
Sleep Outcome Measures 
Sleep diaries. Each child’s sleep intervention varied in length, with the specific 
duration dependent on the rate of the individual child’s progress and/or any 
obstacles or setbacks that may have delayed goal attainment. Michael’s intervention 
was suspended on 18 out of 33 nights due to illness. Sleep diary data concerning at 
least one sleep variable is missing for days 38, 48, 49, 50, 51, and 62 as his mother 
did not report all data on these days. Intervention was implemented for a total of 54 
days for Michael before the decision was made to end treatment. It was at this point 
that his mother determined that she was satisfied that her treatment goals had been 
achieved and that she no longer required the involvement of the research team.  
 
For Robert, co-sleeping data is not reported in the sleep diaries from nights 21-
30 during intervention and as such, this data is not included in the results. Data is 
reported for his 24 nights of intervention. 
Sleep diary data was not reported for one night of Hannah’s intervention, and is 
therefore not included in any analyses.  Duration of night waking data is missing on 
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nights 1, 2, 6, and 7 during baseline, as these times were not reported in the 
corresponding sleep diaries. Data is also missing for various sleep variables on 
nights 9, 10,11,12, 13, 14, 20, 22, and 24 during intervention. 
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Figure 1. Duration of sleep onset latency (mins) during baseline and intervention for 




Effect on sleep onset latency. Figure 1 displays baseline, intervention, and 
(where available) follow-up data for sleep-onset latency (SOL) for all three 
participants. Considerable variability in SOL during baseline was observed for 
Michael and Robert. Hannah on the other hand presented with a comparatively less 
variable SOL over baseline. A variable pattern of SOL continued throughout 
intervention for Michael, while Robert’s SOL appeared to have consolidated and 
become less variable. Some of the data pertaining to Hannah’s SOL during 
intervention is missing, however the available data indicates that there was no 
substantial change from baseline patterns. The follow-up sleep diary data available 
for Michael reveals a return to his variable pretreatment SOL, and within the same 
temporal range reported at baseline. Robert’s reduction in SOL was maintained at 
follow-up, and there was a decrease in the amount of variability when compared to 
intervention. Follow-up data had not been collected from Hannah’s parents at the 
time of submission of this thesis.  
 
Hannah. For Hannah, a variable pattern of SOL was reported during her 
baseline period. SOL ranged from 5 to 20 minutes over the course of this study 
phase. On the first night of intervention, Hannah’s SOL was reported to be within 1 
minute, and then SOL data was not reported for the next 7 nights. From night 16 to 
the end of Hannah’s intervention phase (night 29), her SOL ranged from 5 to 15 
minutes, with the exception of night 23, when her SOL was not reported, and night 
29, when her SOL increased to 40 minutes. The reason for this was unexplained. 
 
Michael. For Michael, his SOL was variable during the baseline phase, 
ranging from 3 to 40 minutes. His longest SOL periods during this phase aligned with 
a bout of illness he experienced from night 8 to night 16. A sharp and immediate 
escalation in SOL (95 minutes) occurred on night 17 when Michael’s intervention 
phase began. This spike is likely to be the result of the removal of parental presence 
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as part of intervention. Following this initial burst, there was no change from baseline 
levels up until with the exception of an 85-minute SOL on night 56 and a 45-minute 
SOL that occurred on night 63. On both occasions Michael had been experiencing 
stomach pains. Following this last burst, there appeared to have been a resolution of 
SOL for the remainder of intervention, however there was a return to baseline levels 
over follow-up.  
 
Robert. For Robert, his baseline SOL was variable (between 10 and 93 
minutes) and typically lasted longer than 30 minutes. From the commencement of 
intervention, his SOL became more consistent, settling within 15 minutes for the first 
7 days of intervention. On night 29, when Robert was staying at his grandparents’ 
house, he exhibited a spike in SOL to 105 minutes. For the remainder of his 
intervention phase (from night 30 to night 42), SOL ranged from 5 to 30 minutes. 
During follow-up, SOL was relatively consistent compared to baseline and 
intervention. During 5/7 nights of follow-up his SOL was 30 minutes and on the other 














Figure 2. Frequency of night wakings during baseline and intervention for the three 
participants, and follow-up for Michael and Robert.  
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Effect on frequency of night wakings. Figure 2 presents data for the frequency 
of night wakings (NW’s) for each of the three children in the study over the course of 
their baseline, intervention, and follow-up phases. During baseline, the frequency of 
NW’s was variable for Robert, almost non-existent for Michael, and consistent but 
low for Hannah. Throughout intervention, the frequency of NW’s increased for 
Michael, and decreased for Hannah and Robert. At follow-up, NW’s were non-
existent for Robert, and almost non-existent for Michael. 
 
Hannah. During her seven-day baseline period, Hannah displayed a relatively 
consistent pattern of NW’s, having one NW on six nights and two NW’s on one night. 
Following intervention, the frequency of NW’s decreased, specifically with nine nights 
of one single NW, and 12 nights with no NW’s.     
 
Michael. Contrary to pre-baseline parental report, Michael displayed a very low 
frequency of NW’s during baseline, with zero NW’s barring one that occurred on 
night 8. The reason for this is likely related to his sleep setting over those particular 
evenings and the subsequent fulfilment of his co-sleeping needs from intial sleep 
onset. During intervention, NW’s occurred during 19 out of 54 nights and ranged 
from one to three NW’s per night. The nights during which NW’s took place were 
typically followed by an absence of NW’s for a period lasting between one to eight 
consecutive nights. One period of consecutive nights without NW’s spanned from 
night 29 to night 53, and then again during the last seven nights of intervention. 
Michael’s lowered frequency of NW’s was sustained at follow-up, during which time 
he had one NW.  
 
Robert.  For Robert, NW’s occurred on all but two nights during the baseline 
phase. The frequency of NW’s over those evenings was highly variable and ranged 
from one to seven. From the commencement of intervention, NW’s were virtually 
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non-existent, with the exception of one NW on night 38. During the follow-up phase 
no NW’s were reported. 
 
Figure 3. Duration of night wakings during baseline and intervention for the three 
participants, and follow-up for for Michael and Robert. 
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Effect on duration of night wakings. Data pertaining to the duration of NW’s for 
the three children in this study across baseline, intervention, and follow-up are 
depicted in Figure 3. The duration of NW’s during baseline was highly variable for 
Robert, and less variable for Hannah. Michael’s single NW during baseline did not 
reveal a pre-treatment pattern of NW duration. Throughout intervention, duration of 
NW’s did not fluctuate significantly for Michael or Hannah. An almost entire 
elimination of NW’s was reported from the introduction of intervention and through to 
follow-up for Robert, and during follow-up for Michael.  
 
Hannah. Over the three consecutive nights of her baseline phase when night 
wakings were reported, the night wakings lasted for 10 minutes. Although NW’s were 
reported as having occurred on nine nights of Hannah’s intervention, data regarding 
the duration of NW’s was not reported for three of those nights. For those reported, 
the duration ranged from 5 to 10 minutes, indicating low variability.  
 
Michael. Michael’s baseline period had one NW that lasted 13 minutes, 
however the single NW did not enable the identification of a pattern of NW duration 
and was at variance with the parent’s previous report. The explanation for this is 
alluded to in the previous section regarding the frequency of NWs. The duration of 
his NW’s was under 5 minutes on 13 of the 17 nights of intervention during which at 
least one NW occurred. During the other five nights of intervention which featured at 
least one NW, Michael’s NW’s lasted between 13 to 28 minutes. With Michael’s 
NW’s not exceeding 30 minutes in length on any occasion over the course of 
baseline or intervention, a relatively consistent pattern of a low duration was 
observed. Michael’s single NW during his follow-up phase lasted for 35 minutes, 
which is a very slight increase from the range of durations that he exhibited 
previously. However, as with his baseline, the one NW during follow-up is not 
enough data to establish a pattern of NW duration following treatment.    
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Robert. For Robert, his duration of NW’s was highly variable, lasting from 7 to 
122 minutes. Robert’s reduction in the frequency of NW’s during intervention was 
paralleled by a reduction in NW duration. NW’s did not occur during follow-up; 




Figure 4. The percentage of the night spent co-sleeping during baseline and 
intervention for the three participants, and follow-up for Michael and Robert.  
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Effect on co-sleeping. Figure 4 displays the baseline, intervention, and follow-
up data for the percentage of the nightly sleep period spent co-sleeping for the three 
children participating in the study. Michael and Hannah engaged in co-sleeping 
every night during the baseline period, and for high percentages of their total nightly 
sleep period. Co-sleeping occurred in Robert’s case over the first few nights of 
baseline, but from then and through to the end of his follow-up, it was no longer a 
presenting problem. Michael and Hannah’s co-sleeping also decreased to 0% with 
the introduction of intervention, and was sustained at that percentage for most of 
their intervention phases, with the exception of a few evenings. For the entirety of 
Michael and Robert’s follow-up phases, co-sleeping sat at 0%. 
 
Hannah. Hannah co-slept for 100% of her total nightly sleep period during each 
night of baseline. Her co-sleeping fell to 0% for almost every night of intervention, 
until night 24. Then for five of the remaining six nights of intervention, her percentage 
of total nightly sleep period spent co-sleeping rose and ranged from 9.7% to 87.5%. 
This is probably a consequence of lapse in treatment adherence on the part of the 
parents at this time. As follow-up data is yet unavailable, it is not possible to 
determine whether the parents reinstated any procedures pertaining to the 
elimination of parental presence/co-sleeping at any point after the cessation of 
Hannah’s intervention phase. 
 
Michael. Co-sleeping occurred every night during Michael’s baseline and for a 
large percentage of those nights. Co-sleeping constituted between 54% and 77% of 
his total nightly sleep period, with the exception of night 7, when 14.9% of the night 
was spent co-sleeping. The percentage of the night that was spent co-sleeping 
reduced to 0% for the first 18 nights of intervention until night 35, when Michael co-
slept with his Mother 13.9% of his nightly sleep period. His co-sleeping reduced back 
down to 0% for the remainder of his intervention phase, with the exception of two 
nights (night 56 and night 63) during which he co-slept with his Mother 100% of his 
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total nightly sleep period. The reduction in co-sleeping that was observed over 
intervention was maintained at follow-up for Michael, during which time his co-
sleeping sat at 0% for all 10 nights of follow-up. 
 
Robert. Within the first five days of Robert’s baseline, there were three nights 
during which he co-slept between 34% and 52% of his total nightly sleep period. Co-
sleeping then displayed a descending trend from night six of his baseline phase, and 
remained at 0% for every night of intervention and follow-up. 
 
Sleep Problem Severity. The SPS scores for each of the three participants at 
each of the three study phases in presented in Table 3. Higher SPS scores indicate 
higher prevalence of co-sleeping, sleep onset delay longer than 15 minutes, and 
night wakings. The trend in the scores over the three phases of the study was 
variable across participants. 
 
Table 3. Comparison of baseline, treatment, and short-term follow-up SPS 
scores for the three participants 
 Hannah Michael Robert 
Baseline 1 4 7 
Treatment 4 1 1 
Short-term follow-up - 0 2 
 
Hannah. Hannah’s low pre-intervention SPS score of 1 increased following 
intervention to 4. Short-term follow-up data was not yet collected for Hannah at the 
time of submission. 
 
Michael. Michael’s SPS scores show a steady reduction in sleep problem 
severity over the three stages of this study. His baseline score of 4 decreases to 1 
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following the commencement of intervention, and then decreases slightly again by 
his short-term follow-up. 
 
Robert. For Robert, his baseline score of 7 was the highest of the sleep 
problem severity scores across the three participants. His score then fell significantly 
to 1 at the time of treatment, and then saw a small increase to 2 at his short-term 
follow-up. 
 
Child Sleep Habits Questionnaire. The results of the CSHQ (Owens et al., 
2000) are displayed in Table 4. Higher scores convey greater difficulties in the 
particular sleep-related variable rated. Total sleep difficulty ratings across the three 
participants at baseline were mixed. At post-intervention, total sleep difficulties 
decreased for Michael and Robert, while slight increase was reported for Hannah.  
 
Table 4. Comparison of Pre- and Post-Intervention Scores on the CSHQ for the 
three participants 
Variable scores Hannah Michael Robert 
 Pre Post Pre Post Pre Post 
Bedtime Resistance 8 9 11 6 6 5 
Sleep Onset Delay 1 1 2 1 2 1 
Sleep Duration 4 5 7 3 3 3 
Sleep Anxiety 6 7 7 4 4 4 
Night Wakings 8 6 9 4 9 3 
Parasomnias 10 11 10 8 10 10 
Disordered Breathing 5 5 4 3 3 4 
Daytime Sleepiness 12 11 11 11 10 11 
Total difficulties 54 55 61 40 47 41 
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Hannah. There was considerable variability across Hannah’s pre- to post-
intervention scores, with the CSHQ variables showing either an increase, decrease, 
or constancy. His night wakings and daytime sleepiness scores decreased, from 8 to 
6 and 12 to 11 respectively. A slight increase in bedtime resistance (from 8 to 9), 
sleep duration (from 4 to 5), sleep anxiety (from 6 to 7), and parasomnias (from 10 to 
11) was seen over the two time points. The remaining variables of sleep onset delay 
(both: 1) and disordered breathing (both: 5) showed no change from pre- to post-
intervention. Despite the above-described variability, Hannah’s total difficulties score 
reflected an overall, albeit minor, increase in sleep disturbance. 
 
Michael. For Michael, his post-intervention scores on all variables were lower 
than his pre-intervention scores, with the exception of daytime sleepiness, which 
remained at 11 at both time-points. The most sizeable decreases were in bedtime 
resistance (from 11 to 6), sleep duration (from 7 to 3), and night wakings (from 9 to 
4). Overall, his total sleep difficulties score decreased significantly from 61 to 40 
following treatment. 
 
Robert. Robert’s scores remained constant from pre-intervention to post-
intervention or decreased on the CSHQ, except for daytime sleepiness, which 
increased from 10 to 11, and disordered breathing, which increased from 3 to 4. His 
scores for sleep duration (both: 3), sleep anxiety (both: 4), and parasomnias (both: 
10) did not change following intervention. Improvements in bedtime resistance (from 
6 to 5), sleep onset delay (from 2 to 1), and most notably, night wakings (from 9 to 
3), were reported. His total sleep difficulties score reflects an overall decrease, from 
47 at pre-intervention to 41 at post-intervention. 
 
Parental Sleep, Well-being, and Relationship Satisfaction Measures 
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PSQI. The global score of the PSQI for the parents of all three children 
participating in the study is presented in Table 7. This gives an impression of the 
quality of the parents’ sleep at pre- and post-intervention. Lower scores on the PSQI 
indicate better sleep quality. The results are mixed across the respondents. 
 
Table 5. Comparison of Pre- and Post-Intervention Global scores on the PSQI 
for the parents of the three participants 
 Hannah Michael Robert  
 Mother Father Mother Father Mother Father  
 Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Max 
Global PSQI 
score 
7 5 4 5 6 7 N/A N/A 9 6 4 5 21 
 
Hannah. Hannah’s mother’s global sleep quality score was 7/21 at baseline 
and decreased to 5/21 following treatment. Her father’s global score increased 
slightly from 4 to 5/21. 
 
Michael. Michael’s mother’s global sleep quality score increased from 6/21 to 
7/21 following the completion of his intervention.  
 
Robert. For Robert’s mother, her global sleep quality score decreased from 
9/21 to 6/21, while his father’s global score showed a slight increase, from 4/21 to 
5/21, over the two time-points.  
 
DASS-21. The participants’ parents’ results for the DASS-21 are presented in 
Table 5. A greater likelihood of psychological distress in the form of each of the three 
dimensions is represented by higher scores. Across the participants’ parents, anxiety 
scores either decreased or remained constant following intervention. Conversely, 
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there was more variability in depression and stress scores. For both variables, three 
of the five respondents scored higher at the second measurement time-point, while 
the remaining two respondents’ scores decreased. All scores were within the normal 
range. 
 
Table 6. Comparison of Pre- and Post-Intervention Scores on the DASS-21 for 
the three participants 
 Hannah Michael  Robert 
Variable Mother Father Mother Father Mother Father 
scores Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post 
Depression 2 1 3 2 0 3 N/A N/A 1 2 0 2 
 (N) (N) (N) (N) (N) (N)   (N) (N) (N) (N) 
Anxiety 12 1 2 0 2 0 N/A N/A 0 0 0 0 
 (N) (N) (N) (N) (N) (N)   (N) (N) (N) (N) 
Stress 11 8 3 5 6 4 N/A N/A 1 3 2 7 
 (N) (N) (N) (N) (N) (N)   (N) (N) (N) (N) 
 
Hannah. Hannah’s parents both scored within the normal range at the two 
measurement time-points. Her mother produced lower scores at post-intervention 
than at pre-intervention for depression, anxiety, and stress. Her father’s scores 
similarly decreased for depression and anxiety, however his stress score increased 
at post-intervention. The decrease in depression scores was slight, from 2 to 1 for 
her mother and 3 to 2 for her father. Her father’s anxiety score decreased from 2 to 
0, and her mother’s anxiety score showed a marked decrease from 12 to 1. 
Hannah’s mother’s stress score decreased from 11 to 8, while her father’s stress 
score increased from 3 to 5. 
 
Michael. Michael’s mother scored within the normal range for all dimensions at 
pre- and post-intervention. His mother’s depression score increased from 0 to 3. For 
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the anxiety and stress dimensions, his mother scored two points lower at post-
intervention compared to pre-intervention, from 2 to 0 and 6 to 4 respectively. No 
data was collected for Michael’s father, as his Mother is his primary caregiver. 
 
Robert. For all dimensions, both of Robert’s parents scored within the normal 
range at pre- and post-intervention. His parents’ depression and stress scores 
increased post-intervention. The increase was slight for depression scores, from 1 to 
2 for his mother and 0 to 2 for his father. Robert’s mother’s score increase was also 
minor for stress (1 to 3), however his father’s stress score increased considerably 
from 2 to 7. His parents both scored 0 at pre- and post-intervention for the anxiety 
dimension. 
 
RQI. The results of the RQI are presented in Table 6, showing the pre- and 
post-intervention global scores for the parents of two of the children in the study 
(Robert and Hannah). Greater partner satisfaction is indicated by higher global RQI 
scores. Across the responding parents, scores either did not change from pre- to 
post-intervention, or increased. Michael’s mother did not complete the questionnaire, 
as she is not in a relationship. 
 
Table 7. Comparison of Pre- and Post-Intervention Scores on the RQI for 
parents of two of the participants 
 Hannah Robert  
 Mother Father Mother Father  
 Pre Post Pre Post Pre Post Pre Post Max 
Global 
RQI 
31 33 39 39 44 44 45 45 45 
 
Hannah. A higher level of partner satisfaction was indicated by Hannah’s father 
(39/45) at baseline than her mother, who rated her partner satisfaction at 31/45 
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before intervention commenced. Hannah’s father’s post-intervention global RQI 
score did not change from pre-intervention. Her mother on the other hand indicated a 
higher level of partner satisfaction post-treatment (33/45) compared to her pre-
treatment rating. 
 
Robert. Robert’s mother and father indicated similar levels of partner 
satisfaction, with scores of 44/45 and 45/45 respectively, and at both measurement 
time-points. 
 
General Child Behaviour Measures. 
VABS-II. The results of the VABS-II at pre- and post-intervention for the three 
children participating in the study are displayed in Table 8. The receptive 
communication scores represent the proficiency with which an individual listens, 
pays attention, and understands, and the expressive communication scores 
represent the level of sophistication in the words and sentences they use in their 
communication. The reported scores indicate the neurotypical age, in years and 
months, that is equivalent to their ratings on various dimensions of the questionnaire. 
A higher score, which reflects an older age, signifies greater ability. For Michael and 
Robert, their age-equivalent scores on both the receptive and expressive 
communication dimensions either increased or did not change following treatment. 
Contrastively, Hannah’ scores showed a decline in receptive and expressive 
communication. 
 
Table 8. Comparison of Pre- and Post-intervention receptive and expressive 
communication age-equivalence scores on the VABS-II for the three participants 
 Hannah Michael  Robert 
 Pre Post Pre Post Pre Post 
Receptive communication 3-2 2-4 2-3 2-9 1-8 1-10 
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Expressive communication 4-10 3-11 1-10 1-11 1-11 1-11 
(Note: X-X = year-month) 
 
Hannah. For Hannah, there appears to have been a significant regression in 
both her receptive and expressive age-equivalent communication scores from pre- to 
post-intervention. Her pre-intervention receptive score of three years and two months 
decreased to two years and four months at post-intervention. Likewise, Hannah’s 
expressive score at baseline was four years and 10 months, which then decreased 
to three years and 11 months following intervention. 
 
Michael. Receptive and expressive communication age-equivalent scores 
increased from pre- to post-intervention for Michael. His pre-intervention receptive 
score of two years and three months increased by six months following intervention, 
while his expressive score increased by one month, from one year and 10 months to 
one year and 11 months. This slower increase for expressive communication is likely 
related to some developmental factor, perhaps highlighting an especially challenging 
area of development for Michael. 
 
Robert. Robert’s age equivalent scores on the receptive and expressive 
communication domains remained fairly consistent over the two time-points. Robert’s 
receptive score was one year and 8 months at baseline and then increased by two 
months following intervention. His expressive communication score of one year and 
11 months was sustained from pre- to post-intervention. 
 
CBCL. The pre- and post-intervention results of the CBCL for the three children 
are displayed in Table 9. The CBCL, which is completed by parents, brings to light 
possible problems of a behavioural or emotional nature in a child. A greater level of 
problem is indicated by a higher score. 
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Table 9. Comparison of Pre- and Post-Intervention Internalising, Externalising, 
and Total T-scores on the CBCL for the three participants 
 Hannah Michael Robert 
 Pre Post Pre Post Pre Post 
 Score R Score R Score R Score R Score R Score R 
Internalising behaviours  59 N 48 N 52 N 57 N - - 52 N 
Externalising behaviours 73 C 62  B 57 N 55 N - - 51 N 
Total Score 72 C 63 B 58 N 59 N - - 54 N 
(Note: R= Range; N=Normal; B=Borderline; C=Clinical) 
 
Hannah. Hannah’s parents gave her scores that reflect a reduction in 
internalizing and externalizing behaviours following intervention and a shift in score 
ranges. For internalizing behaviours, her score remained within the normal range, 
but decreased from 59 at pre-intervention to 48 at post-intervention. With regard to 
externalizing behaviours, Hannah shifted from the clinical range to the borderline 
range with her scores of 73 and 62.    
 
Michael. For Michael, his mother’s ratings did not change significantly from pre- 
to post-intervention. His mother gave him a rating of 61 for internalizing behaviours 
at baseline, which placed him in the normal range. Michael remained within the 
normal range for internalizing behaviours, with a score of 57 following intervention. 
Similarly, for externalizing behaviours, Michael fell within the normal range at pre- 
and post-intervention, with scores of 57 and 55 respectively.  
 
Robert. Pre-intervention CBCL data was not collected for Robert, however his 
parents scored him in the normal range for internalizing and externalizing behaviours 





Hannah. Hannah’s mother stated that they were satisfied with the intervention 
process and the treatment procedures suggested, especially the Sleep Story, 
Groclock, and restriction of daytime napping, saying that they were “easy to 
implement and effective”. Of the Sleep Story, she said that she felt that it was 
particularly impactful for Hannah, and that Hannah “enjoyed that it was about her” 
and that it “told her really clearly what [they] wanted her to do”. Her mother reported 
that Hannah had become very familiar with her bedtime routine following the 
consistent reading of the Sleep Story over the course of intervention. Some 
disruption that Hannah’s mother felt that the study caused involved the amount of 
psychometrics that they had been asked to complete at pre- and post-intervention. 
Additionally, she felt unsure as to “whether the [psychometric] data gathered was 
meaningful” and necessary. Hannah’s mother also reported that the camera 
equipment stopped working during treatment and that the red light on the equipment 
disrupted her own and Hannah’s sister’s sleep, when they co-slept together in 
Hannah’s room. According to her mother, Hannah’s only persisting sleep problem 
following treatment involved toileting difficulties, wherein Hannah was still wearing a 
nappy during the night, and sometimes wet the bed. She also stated that Hannah’s 
behaviour at school had improved in response to intervention, specifically that she is 
“more attentive to learning” and she is able to “concentrate easier”. Hannah’s mother 
noted that her daughter’s improved sleep as a result of intervention had positively 
impacted herself and Hannah’s younger sister, with both family members 
consequently having experienced improved sleep.  
 
Michael. Michael’s mother described the intervention as good overall, and that 
having a treatment formulated by someone with a fresh perspective brought to light 
the “common sense” solutions to which she had become “oblivious”. She noted that 
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the bedtime routine, goal setting aspects of treatment were helpful in achieving the 
desired sleep outcomes, but the social story was particularly effective. She reported 
that Michael was very engaged with the social story and would enjoy reading it 
multiple times each night. Michael’s interest in the social story lessened over the 
course of the intervention as he was eventually able to grasp the routine and 
expectations that it set out. Michael’s mother expressed that the intervention could 
be improved through better communication regarding deadlines for the completion of 
psychometrics and the organization of intervention resources such as rewards. She 
suggested that a flow chart could be provided that clearly stipulates the entire 
intervention process including such deadlines, to give families the opportunity to 
prepare and consequently prevent any delays in the intervention process. She also 
noted that she would have liked to have seen some graphs or visual representation 
of Michael’s progress during each of the study phases, along with a written summary 
at the end of their involvement in the study. Michael’s mother noticed that Michael’s 
mood was better following the good night’s sleep that he was now able to enjoy 
following treatment. She stated that they were “still working on things but there has 
been a huge change” with respect to Adam’s ability to sleep through the night, as 
well as her own sleep. However, she reported that she still struggled to relax once in 
bed herself, as she is still “alert to any sounds” and anticipates Michael waking.  
 
Robert. The intervention and overall study process was “great” according to 
Robert’s mother.  She noted that despite the simplicity of Robert’s intervention, 
positive change in his sleep-related behaviour was achieved. His mother reportedly 
believed that the faded bedtime procedure was particularly effective in reducing his 
SOL, and that Robert had become rather fond of the Groclock and enjoys switching 
it on at night. Robert apparently understands what the sun and the star displays on 
the Groclock signify, and is able to communicate to other what they mean with 
respect to his sleep and wake times. She also felt that the mere involvement of the 
research team and Robert’s awareness of being monitored by the camera may have 
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prompted the immediate reduction seen in his bedtime resistance. Robert’s mother 
said that she had found the amount of psychometrics and paperwork overwhelming, 
and did not understand their purpose. She suggested that it might be helpful for 
parents to be given a better explanation for the reasoning behind the administration 
of the questionnaires and also to be provided with some information regarding the 
changes seen in the various measured variables from pre- to post-intervention. 
Robert’s mother recognized that sleep had improved for everyone in the family 
following Robert’s intervention, and in addition stated that she and Robert’s father 
were no longer worried about Robert staying in his own bed throughout the night. 
 
TARF-R. The results of the TARF-R are presented in Table 10. Overall, the 
three families that completed the intervention regarded the treatment to be highly 
acceptable, reasonable, comprehensible, affordable, and effective. There was some 
variability in the parents’ perceptions of the disruption caused by the treatment and 
the time it took to carry out intervention. 
 
Table 10. Post-Intervention Treatment Acceptability Scores from TARF-R for the 
three participants 
 Hannah Michael  Robert Max score 
Variable scores Mother Father Mother Father Mother Father  
Total Acceptability 93.5 93.5 99 N/A 110 110 121 
Reasonableness 18.5 18.5 18 N/A 21 21 21 
Willingness 15 15 21 N/A 21 21 21 
Effectiveness 17.5 17.5 17 N/A    16    16 21 
Cost 13 13 14 N/A 14 N/A 14 
Negative Side-Effects 14 14 18 N/A 18    18 21 
Disruption/Time 15.5 15.5 11 N/A 20 20 21 
Problem Severity ° 8 8 8 N/A 10 10 14 
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Understanding of Treatment ° 6 6 6 N/A 5 5 7 
 
° = not included in the Total Acceptability score 
 
Hannah. Hannah’s mother and father were completely consistent in their 
ratings on all dimensions of the TARF-R, beginning with a high rating of overall 
treatment acceptability (both: 93.5/110). Her parents found the intervention to be 
reasonable (both: 18.5), effective (both: 17.5/21), and cost-effective (both: 13/14). 
Hannah’s parents reported that while they have a high level of understanding of the 
intervention (both:6/7), their willingness to implement the intervention was at a 
moderate level (both: 15/21). They perceived the Hannah’s intervention as 
moderately disruptive and time-consuming (both: 15/21) and bringing with it some 
negative side-effects (14/21). Hannah’s parents considered her sleep behaviours 
post-intervention to be moderately problematic compared to her peers of the same 
age (both: 8/14). 
 
Michael. Michael’s mother reported a relatively high level of overall treatment 
acceptability (99/121). She also considered the intervention to be reasonable (18/21) 
and effective (17/21). His mother rated her willingness to implement the intervention 
very highly, with a maximum score of 21/21, and she reported a high level of 
understanding of treatment (6/7). Michael’s mother also perceived the intervention to 
be very economical (14/14). She reported there to have been some negative side-
effects (18/21) of treatment, and a high-level of disruption, with a rating of 11/21. 
Michael’s mother perceived his sleep behaviour problems as moderate compared to 
his same-aged peers following intervention (8/14).  
 
Robert. For Robert, his parents were in complete agreement in their ratings on 
the TARF-R. Both his mother and father showed a high-level of treatment 
acceptability overall (both: 110/121) and perceived the treatment to be very 
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reasonable (both: 21/21). Results suggest that both parents were very willing to carry 
out the intervention (both: 21/21) and had a moderate understanding of treatment 
(both: 5/7). They rated the effectiveness of the intervention a 16/21. Robert’s parents 
perceived the intervention to have been very affordable (both: 14/14), and caused a 
low-level of disruption and did not require a lot of time to implement (both: 20/21). 
They rated the overall effectiveness of the intervention a 16/21. They also reported 
that intervention produced some negative side-effects (both: 18/21). Following 
intervention, Robert’s mother and father deemed his sleep behaviour problems to be 







This study provides some encouraging evidence for the effectiveness of FBA-
based behavioural interventions in the treatment of sleep difficulties of children with 
RGND. Each of the participants exhibited improvements for most sleep-related 
variables following intervention, illustrating the effectiveness of the selected sleep 
interventions within this cohort. Consistent improvement across neither parental 
wellbeing measures, nor measures of general child behaviour, was observed as a 
result of treatment. Despite this, parents of all three participants proved to be highly 
satisfied with the intervention process and intervention itself. 
 
Research Questions 
Three research aims guided the current study: 1) to investigate the 
effectiveness of FBA-based interventions in the treatment of sleep disturbance 
amongst children with RGND; 2) to explore any changes to general child behaviour 
and parent wellbeing following the treatment of sleep disturbance; and 3) to examine 
parents’ ratings of treatment acceptability and their experiences regarding the 
assessment and treatment process. 
 
Study findings  
The sleep diary data revealed an overall sustained improvement across 
dependent sleep-related variables from pre- to post-intervention for the children in 
this study. There was no change in SOL found for Hannah following intervention. 
SOL remained variable throughout all phases for Michael, but there was a clear 
PERB at beginning of intervention, and Robert progressed from highly variable SOL 
at baseline to a more consistent pattern. A consistently low frequency of NW’s was 
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observed in Hannah’s case over all phases, while still displaying an overall decrease 
with intervention, whereas Michael’s low frequency of NW’s at baseline also 
demonstrated a PERB with the introduction of intervention, followed by a return to 
baseline levels at follow-up. NW’s appeared to have been eliminated from the 
beginning of intervention, and the effect was maintained at follow-up. Co-sleeping 
was eliminated for both Hannah and Michael as intervention commenced, however 
Hannah showed some deterioration nearing the end of treatment.  
 
The results of the parent-reported CSHQ and SPSS echoed these findings 
regarding the participants’ sleep following treatment for the most part, with Michael 
and Robert being reported to have shown reductions in total sleep difficulties and 
sleep problem severity respectively, while Hannah demonstrated a slight increase. 
 
The utilization of FBA could be credited with the progress made by the three 
children, given that the assessment protocol allowed for the formulation of 
individualized interventions which targeted the specific sleep problems being 
presented by each of the participants, addressed the precipitating factors and 
function of the behaviour in question, and took into consideration the child’s and their 
family’s needs, preferences, and goals. In the few instances where the children 
exhibited a behavioural regression following the introduction of intervention, or no 
change, it may be that extraneous factors interfered with the intervention process 
(e.g., reduction in parental motivation to implement intervention; changes to sleep or 
home environment such as sleep-overs or visitors staying over) or the child’s 
capacity to respond positively and optimally to treatment (e.g., illness; developmental 
changes). 
 
Outliers, anomalies, and interesting observations.  
Hannah. Despite a large immediate treatment effect, Hannah’s progress with 
regard to co-sleeping deteriorated towards the end of treatment. The information 
	 119	
offered in her sleep diaries indicate that the parents’ adherence to treatment was low, 
which could explain the decline. The parent-reported TARF-R willingness scores 
support this explanation as they imply that Hannah’s parents were not highly motivated 
to implement the recommended intervention procedures, at least at the time that the 
TARF-R was completed by parents, upon completion of the intervention phase.  
 
Hannah had a low and decreasing SOL in baseline, however there was no 
evidence of systematic improvement in treatment. The descending trend in SOL 
before the introduction of treatment may suggest that this problem was improving 
naturally and without intervention. The lack of progress observed in response to 
intervention may simply indicate that by that point her SOL had improved 
independently to an appropriate duration for Hannah, that being between five to 15 
minutes.  
 
There was an increase in Hannah’s SPS and CSHQ scores following treatment, 
which was echoed in her sleep diary data regarding co-sleeping. As has been 
previously discussed and in fact self-reported, Hannah’s parents were low in 
motivation by the end of intervention. No specific explanation for this was provided, 
however there are numerous possible reasons for anyone to lose motivation, and it is 
especially understandable given the intensity of the intervention and the challenges 
that present when attempting to change a child’s behaviour (e.g., PERBs, lack of 
parental sleep, stress over progress).  
 
Robert. Following his unstable and variable SOL during baseline, Robert’s SOL 
became much more stable from the beginning of intervention, with the exception of 
one spike on night 30. On this night Robert had a SOL of 105 minutes. The only 
explanation that could be drawn from his sleep diaries to account for this anomaly is 
the fact that he spent that night at his grandparents’ house. After this instance, his 
SOL returns to a more stable, but steadily increasing trend toward the end of 
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intervention. It is plausible then to posit that the change in Robert’s environment 
(sleep conducive discriminative stimuli), and the circumstances and people around 
which he was to fall asleep disrupted his ability to fall asleep. This behavioural 
response to inconsistency in his routine and surroundings demonstrates the 
importance of upholding sameness when it comes to sleep interventions and seeing 
desired behavioural change.  
 
Similar to Hannah’s case concerning SOL, the descending pattern seen in 
Robert’s co-sleeping during baseline may signify organic improvement in 
independent sleep initiation without parental presence. This could have resulted from 
developmental factors, or possibly a change in the parents’ method or ability to 
manage Robert’s co-sleeping.  
 
Michael.  Michael’s data concerning NW’s during baseline did not reflect earlier 
descriptions of his sleep disturbance given by his mother. While he had been 
reported to have consistently woken during the night when he fell asleep initially in 
his own bed, at which time he could join his mother to co-sleep with her in her bed, 
he only had one brief NW during his entire baseline phase. This discordance is likely 
resulting from the fact that for the majority of nights during baseline, Michael began 
his night sleep in his mother’s bed, and therefore did not need to wake and instigate 
co-sleeping, as he was already in the presence of his mother.  
 
After a short period of eliminated NW’s around the mid-point of intervention, 
Michael’s progress began to deteriorate from night 56 until night 64, after which time 
he had no NW’s for the remainder of his treatment phase, and for almost his entire 
short-term follow-up. The reason for this 10-day long period of increased NW’s 
appear to be related to the sleep resistance that was reported in his sleep diaries 
over that time. It was noted in the sleep diaries that Michael’s grandfather was the 
one responding to his wakings during these nights, which could suggest that the 
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presence of someone other than his mother at night may have unsettled him 
somewhat and provoked him to resist his typical nighttime routine. If this is the case, 
then it emphasizes Michael’s need for consistency in routines to support positive 
sleep behaviour. 
 
While co-sleeping was effectively eliminated for Michael following the 
introduction of intervention, he co-slept for 100% of the night with his mother on 
nights 56 and 63, creating two spikes in his data-set toward the end of intervention. 
The reason for these outliers is easily explained by the fact that Michael and his 
mother were staying at his grandfather’s house on these instances and had to share 
a bed.  
 
Research Question One 
Not only do the results of this study lend some support for the effectiveness of 
FBA-based behavioural interventions for sleep problems, they further the research 
through the application of such approaches with children with RGND.  
 
Through FBA, NW’s were identified as being a feature of all three children’s 
sleep disturbance prior to treatment, although this was not reflected in Michael’s 
sleep diary data for his 16-day long baseline period immediately preceding 
intervention, which was largely free of NW’s. Subsequently, a combination of 
procedures including a social story, discriminative stimulus for sleep/wake time, 
extinction, and a reward system was devised to resolve the children’s NWs, on the 
grounds that the function of this behaviour was found to be to procure parental 
attention, as well as the sensory stimulation of physical contact for Michael. This was 
also determined to be the function behind the pre-treatment co-sleeping in which 
both Michael and Hannah had been engaging, henceforth these intervention 
procedures were intended to treat this problem also. A treatment effect for the 
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frequency of NW’s was demonstrated early in treatment for Hannah and Robert. 
Robert’s decreased frequency in NW’s from high variable numbers at baseline to 0 
upon commencing with treatment was maintained at follow-up, whereas Hannah 
returned to her baseline frequency by the end of intervention, from night 19. Night 
wakings did not occur for Michael until a clear response to the introduction of 
intervention, when his frequency of NW’s increased from 0 to 3. Following 
considerable variation during intervention, Michael’s NW’s returned to his baseline 
frequencies at follow-up. The duration of NW’s treatment effects mirrors the pattern 
observed in the frequency of NW’s across the participants. With respect to co-
sleeping, Hannah and Michael displayed a large and immediate treatment effect. For 
Hannah, these treatment gains deteriorated rapidly towards the end of intervention, 
however for Michael the effect was maintained through to follow-up. The 
improvement seen in the boys’ co-sleeping, and downturn seen in Hannah’s co-
sleeping may be a result of differences in parental adherence to treatment. 
 
Then again for early-morning wakings and sleep onset latency problems 
observed in Hannah and Robert, FBA served to inform treatment. It was reported at 
initial assessment that the two children would in these occurrences engage in 
preferred activities or entertaining oneself with preferred objects (e.g., toys). From 
such information, the function of these problematic sleep behaviours was determined 
to involve escape from bed in order to relieve boredom from lack of sleepiness. The 
rationale behind this conclusion was that the children were not fatigued enough to 
either fall asleep at their pre-intervention bedtimes or wake at an appropriate time in 
the mornings, evidenced by the fact that they were seeking out stimulating activities 
and objects that one would in a wakeful state. The proposed tactics to resolve these 
issues were to enforce a faded bedtime procedure, keep to a specific sleep/wake 
schedule, and to prevent daytime napping. It was hypothesized that these 
procedures would work to increase biological sleep pressure. Following the 
implementation of these treatment methods, Robert displayed a reduction in SOL 
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and presented with a much more consistent range of SOL durations, compared with 
his baseline patterns. Hannah’s SOL appeared to have been improving 
independently during baseline, before the introduction of intervention. Nevertheless, 
her SOL continued to consolidate throughout intervention, suggesting that even if it 
was not intervention that was the catalyst for behavioural change, it did not make 
matters worse and perhaps even facilitated the maintenance of her improvement. 
Although not graphed, early morning wakings were eliminated for both children upon 
the commencement of intervention. These findings suggest that the intervention 
procedures that were suggested based on the results of FBA had a positive effect on 
the SOL and early morning wakings of the two participants. 
 
FBA has been shown to be more effective than those that do not conduct this 
assessment procedure (Beavers et al., 2013; Hanley, 2016; Spruyt & Curfs, 2015). 
FBA has received some attention in the literature, and demonstrated its ability to 
guide the development of interventions for children with developmental disabilities 
(Brown et al., 2013; Didden & Sigafoos, 2001; Hanley, 2016; Hanley et al., 2014; 
Kodak & Piazza, 2008). A substantial evidence-base supporting the use of FBA 
within populations with higher prevalence developmental disabilities has 
subsequently amassed (Campbell, 2003; Hanley et al., 2014; Hansen & Wadsworth, 
2015), however only two studies have made use of a formal functional assessment 
procedure in the formulation of sleep interventions for children with RGND (Didden et 
al., 1998; Weiskop et al., 2005). Utilization of FBA increases the likelihood of the 
overall effectiveness of treatment, by only suggesting the inclusion of methods that 
are proven to be effective at rectifying the specific established causal association 
with the specific problematic behaviour. Furthermore, FBA cuts down on redundant 
treatment procedures that would likely complicate matters and unnecessarily over-
burden the parents, who are typically charged with carrying out such interventions. 
The treatment effects produced in the current study provide support for the existing 
body of literature that attests to the notion that multiple factors are at play in the 
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presentation of sleep problems, and that multi-component interventions are therefore 
necessary to treat them (Singh & Zimmerman, 2015; Spruyt & Curfs, 2015), by 
providing further validation for the effectiveness and applicability of the procedure in 
the treatment of sleep problems in children with RGND. 
 
While the progress made by the participants implies that the intervention 
package as a whole was effective, as evidently was the use of FBA to inform the 
selection of specific procedures, it is difficult to attribute the treatment effects to the 
specific intervention procedures, especially considering that all procedures were 
implemented simultaneously at the commencement of the intervention phase. One 
way in which this investigation could be expanded upon could be to stagger the 
different interventions such that each individual procedure is introduced one by one, 
so that they can be measured separately. This would therefore enable more precise 
inspection of associations between certain intervention procedures and change in 
outcome variables. 
 
Research Question Two 
The impact of successful treatment on general child behaviour, communication, 
and RGND symptomatology. The three children in this study completed their 
individualized sleep interventions successfully. Improvement in their child’s daytime 
behaviour following treatment, specifically in relation to mood, was noted by the 
parents of two of the participants, as reported in the post-treatment interviews. These 
reports of perceived behavioural change were somewhat supported by the children’s 
scores on the CBCL. The participants’ CBCL data uncovered other behavioural 
changes that were not detected by the parents. Similarly, some gains in receptive 
and expressive communication were seen in two of the participants according to 
their pre- and post-intervention VABS-II scores.  
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CBCL. The internalising behaviour scores of Michael and Hannah at baseline 
were within the normal range, but for externalising behaviours and their total scores, 
Michael scored within the normal range while Hannah scored within the clinical 
range. The CBCL was not completed at baseline by Robert’s parents, however his 
post-intervention scores were all within the normal range. Michael’s scores did not 
change significantly following treatment, and he remained within the normal range for 
internalising and externalizing behaviours. Hannah on the other hand produced 
significantly lower scores following intervention, shifting from the clinical range for 
externalising behaviours and total score at baseline, to the borderline range post-
intervention. Her post-intervention internalising behaviour score remained within the 
normal range. In the case of the participants of the current study, it appears that 
there was little change in the children’s internalising and externalising behaviours 
when they were within the normal range prior to commencing with treatment, but a 
sizeable improvement in said variables was observed when they fell within the 
clinical range, and thus more severe, before intervention was introduced.  
 
The improvement seen in Hannah’s externalising behaviours following the 
sleep intervention could be attributed to a number of possible causes. One such 
explanation could be that there are similar mechanisms behind sleep difficulties and 
other problem behaviours. The same antecedent- and consequence-related factors 
that are maintaining sleep difficulties may also be maintaining externalising 
behaviours in a child. Alternatively, it may be that the lack of sleep resulting from 
sleep disturbance acts as a catalyst for other challenging behaviours. It is also 
possible that the skills and techniques learnt by parents through the sleep 
intervention, and the improved sleep that they might enjoy as a consequence of their 
child’s improved sleep behaviours, may aid the parents in being able to better 
manage their child’s externalising behaviours in a more informed and rested manner. 
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VABS-II. Before intervention, the three participants’ age-equivalent scores on 
receptive communication put them at a significantly younger age and 
correspondingly lower level of competency than their neurotypical, same-aged peers 
according to the VABS-II. This discrepancy was even greater for expressive 
communication for two of the participants. The largest disparity in this sense was 
observed in Michael, who had an age-equivalent score in receptive communication 
at baseline that was eight years younger than his actual age of 12 years at the time 
of intervention. His baseline age-equivalent score in expressive communication was 
10 years younger than his actual age. For Robert, the difference between his actual 
age at the time of intervention (six years) and his age-equivalent receptive and 
expressive communication scores was smaller, but still a sizeable gap of 
approximately five years at baseline. Of the three children, Hannah produced pre-
intervention scores that were the closest to her actual age of six, with an age-
equivalent score three years younger for receptive communication and two years 
younger for expressive communication. Michael’s and Robert’s age-equivalent 
scores on both the receptive and expressive communication dimensions either 
remained constant or increased following intervention. A regression in receptive and 
expressive communication scores was observed in Hannah’s case.  
 
The variable directions of change in VABS-II scores across participants could 
indicate that the relationship between the communication variables and intervention 
is correlational rather than causational. It may be that the changes in receptive and 
expressive communication observed following intervention were instead a result of 
other extraneous factors. These could include a developmental regression as part of 
their RGND, or perhaps some events or stress experienced by the child causing 
them to revert back to a simpler level of communication. Further research is needed 




The effectiveness of successful treatments on parent wellbeing. Improved 
parental sleep following their children’s interventions was reported in all three post-
treatment interviews. The mothers of the three participants stated that they 
experienced better sleep as a result of their children’s progress. Michael’s mother 
also noted that she enjoyed more personal space with the elimination of co-sleeping, 
and Hannah’s mother reported that she felt less stress following intervention, which 
she attributed partially to the improvements in Hannah’s sleep behaviours. Robert’s 
mother no longer worried about Robert during the night and therefore was able to 
sleep more peacefully. These findings mirror the testimonies reported in the literature 
related to behavioural sleep interventions carried out within the family context of 
children with RGND and higher prevalence neurodevelopmental disorders, such as 
ASD (Allen et al., 2013; Brown et al., 2013; Cortesi et al., 2010; Weiskop et al., 
2005). These accounts given at post-treatment by the parents were supported 
somewhat by the pre- and post-intervention data obtained from the DASS-21, PSQI, 
and RQI.   
 
DASS-21. Before intervention, depression, anxiety, and stress scores were all 
within the normal ranges for the parents of the three participants, which is out of line 
with what would be expected, based on the literature. Past research has found that 
parents of children with RGND, such as RTT, AS, PWS, Cornelia de Lange 
syndrome, and Cri du Chat syndrome, are at risk for higher levels of depression, 
anxiety, and stress in general (Griffith, Hastings, et al., 2011; Hodapp et al., 1997a; 
McDougall, Kerr, & Espie, 2005; Richman et al., 2009; Sarimski, 1997; Van den 
Bourne et al., 1999; Wulffaert et al., 2009). Although their baseline results displayed 
healthy levels of depression, anxiety, and stress, the changes observed in the 
parents’ DASS-21 scores following intervention were mixed. Anxiety scores either 
decreased or remained constant following intervention for all of the participants’ 
parents. Of note were Hannah’s mother’s anxiety scores, which decreased 
significantly from 12 to 1. While the DASS-21 does not provide any explanation for 
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the changes observed in the parents’ scores (Moore, 2004), it is possible that 
decreases in parental anxiety may be related to the higher quality sleep experienced 
by parents, afforded by their children’s improved sleep following intervention. It must 
also be considered that extraneous variables, such as a decrease in stress relating 
for instance to work or other family members, may be responsible either partially or 
entirely for this progress. Depression and stress scores on the other hand showed 
greater variability in their direction of change. Depression scores increased slightly 
for Michael’s mother, who stated that she was still struggling to relax still in the night, 
and was still alert to any sounds, despite Michael’s improvement. Her stress scores 
conversely showed a decrease. Both Robert’s and Hannah’s parents’ stress scores 
increased following intervention. Depression scores increased slightly for Robert’s 
parents, and decreased slightly for Hannah’s parents. Robert’s, Hannah’s, and 
Michael’s parents’ post-treatment interviews elucidated an issue they had with the 
amount of psychometrics that they were required to complete at baseline and then 
again following the end of treatment. This could be a potential factor behind the 
increase in their depression and stress scores, however it is also possible that 
extraneous variables are the cause.  
 
PSQI. Across the three families that participated in the current study, the 
impact of intervention on parental sleep quality, according to the results of the PSQI, 
were mixed. Improved global sleep quality scores were seen following treatment for 
Robert’s father, Hannah’s father, and Michael’s mother. Contrarily, lower global 
sleep scores were obtained post-intervention for Robert’s mother and Hannah’s 
mother, compared to their pre-intervention scores. This finding is inconsistent with 
other research which has found positive correlations between child sleep problems 
and lower parental sleep quality (Boergers et al., 2007; Lopez-Wagner et al., 2008; 
Robinson & Richdale, 2004; Wiggs & Stores, 2001). The post-treatment interviews 
with Robert’s and Hannah’s mothers do not provide any unequivocal explanations for 
their worsened sleep. However, it is reported that Hannah’s mother was still co-
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sleeping with her younger sister, which could be a possible contributor to the 
decrease in her global PSQI score at that time. For both mothers, it is conceivable 
that some unrelated factors may be behind their reduced sleep quality reported at 
post-treatment, such as stress relating to work or relationships with friends or family 
members. 
 
RQI. Prior to commencing with intervention, Robert and Hannah’s parents had 
moderate to very high global scores on the RQI, which signifies a high level of 
satisfaction with their relationships. Comparing these scores to the post-intervention 
scores, it appears that across the parents, their relationship satisfaction remained 
consistent, or increased slightly, as was the case for Hannah’s mother. It could be 
theorized that this increase in ratings of relationship satisfaction for Hannah’s mother 
reveals a secondary effect of treatment, whereby improved child sleep behaviours 
subsequently decreased stress that may have been afflicting familial relationships. It 
also is possible that other extraneous variables might be responsible for the 
increased relationship satisfaction reported by Hannah’s mother, such as the 
reduction in work and study stressors that she described in her post-treatment 
interview. 
 
Minimal attention has been paid to secondary outcomes of behavioural sleep 
intervention for children with RGND, such as those explored in this study (i.e., 
general child behaviour and parental wellbeing, sleep, and relationship satisfaction). 
Moss and colleagues (2014) did not find a statistically significant change in parental 
stress following treatment, however, a shift from “clinical” to “normal” range from 
baseline to intervention respectively, was found for the treatment group. This was 
contrasted by the control group, which remained in “clinical” ranges over all study 
phases (Moss et al., 2014). These results mirror those of some of the parents of 
participants in the current study. 
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Due to the results from psychometrics measuring parental wellbeing and 
relationship satisfaction being largely mixed within and between respondents, a 
definitive treatment effect cannot be confirmed. While anecdotal evidence offered 
through post treatment interviews with the parents indicate that there were some 
self-perceived improvements in personal well-being and sleep which they felt were 
associated with their child’s sleep intervention, which is in line with past research 
examining the association between the TD children’s sleep and parental wellbeing 
(Hauck et al., 2012; Hiscock et al., 2008; Lam et al., 2003; Mindell, Telofski, et al., 
2009b), it is highly plausible that any positive effect that treatment might have had on 
such secondary outcomes could be nullified by life stressors unrelated to their child’s 
sleep behaviours (e.g., work-related or financial stress). It is possible that this was 
the case for those parents whose psychometric results showed a decline in 
wellbeing and/or sleep variables. 
 
Research Question Three 
Parent understanding and acceptability of treatment. All in all, the results of the 
current study convey a sufficient level of satisfaction felt by the parents of the three 
participating children, with regards to the intervention process, and interventions 
themselves. The participants’ parents’ personal accounts of the intervention and 
intervention process, communicated by way of the post-treatment interviews, also 
highlighted an unanimity of perception that the treatment was effective and easy to 
implement. Whilst the post-treatment interviews contained many positive opinions, all 
three sets of parents emphasized that they were inconvenienced by the amount of 
psychometrics that they were instructed to complete at pre- and post-intervention. 




These parental perceptions of the intervention process and outcomes were 
corroborated by the results of the TARF-R. Across the all parents, treatment 
acceptability scores were high, as were their ratings on the reasonableness and 
effectiveness of treatment. The parents’ scores also indicate that they had a good 
understanding of treatment. Maximum scores for willingness were given by all 
parents, except Hannah’s mother and father, who gave moderate scores. These 
lower self-report ratings of willingness to carry out the intervention with Hannah were 
validated by her parents’ noncompliance with various aspects of her intervention. 
Michael’s mother’s and Hannah parents’ scores indicate moderate levels of 
disruption and time required to implement the interventions. Conversely, Robert’s 
parents scores represent a low level of disruption and time required, which was 
reiterated in their post-treatment interview when they stated that Robert did not 
require a very intensive intervention for his behaviour to change. The results also 
suggest that all of the parents encountered some negative side-effects of 
intervention. 
 
The incorporation of FBA into the assessment and treatment development 
processes could be credited for these high treatment acceptability scores and 
positive personal narratives concerning the intervention. FBA is conducted not only 
to facilitate the development of interventions tailored to the individual child, but also 
to their family who serve as the agents of change in the implementation of 
intervention. Through FBA, the child’s unique presentation of problem behaviours, 
their developmental history, their family and home environment, and the level of 
support and motivation offered by their parents/caregivers, are ascertained and used 
to inform their treatment plan. As such, the consideration given to the families and 
the effort made to create the most feasible and non-disruptive intervention possible 
is likely to enhance the social validity, comprehensibility, and achievability of 
treatment. As intervention progresses, collaboration with the family may be 
continued in a similar vein, taking into account any observations made by the 
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families and adjusting the intervention to meet their changing preferences and 
needs. Moreover, interventions that are developed following this FBA-informed 
protocol are more likely to be implemented as instructed and adhered to, 
consequently achieving more positive treatment outcomes (Moore, 2004; Reimers, 
Wacker, & Koeppl, 1987). The benefits of conducting FBA and collaborating with 
families throughout the intervention process that is highlighted by the current study 
echoes the findings of other studies that have attributed their treatment success to 
their use of these approaches (Derby et al., 1997; Jin et al., 2013; Moore, 2004; 
Piazza, Hanley, & Fisher, 1996; Turner & Johnson, 2012; Wacker et al., 1998; 
Weiskop et al., 2005). 
 
Future research of this kind could benefit from a reduction in the amount of pre- 
and post-treatment psychometrics, including only those measures that are absolutely 
necessary to the investigation. In addition, the provision of a more concrete 
explanation and justification for their purpose and importance to parents is advised, 
based on the findings of this study. This should not only increase treatment 
acceptability, but may also improve treatment adherence and parents’ willingness to 
implement the intervention accurately. 
 
Limitations of the study 
Despite the encouraging results of the current study, several limitations must 
be considered alongside the findings discussed. These include the inability to 
attribute treatment effects to a specific intervention component exclusively, its 
dependence on psychometrics for general child behaviour and parental wellbeing, 
sleep, and relationship satisfaction data, hindered generalizability of results, absence 
of inter-observer agreement for primary sleep data, and a shortage of follow-up data.  
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The experimental design of the current study allows for certain conclusions to 
be derived from the results. That is to say that just as the function of problematic 
sleep behaviour unearthed through FBA is regarded as instigating and maintaining 
said behaviour, the function of the alterations in the sleep environment made through 
intervention may be recognized as being responsible for the behavioural change 
observed (i.e., reward/reinforcement; sense of self-efficacy or competency on the 
part of the child). Nonetheless, the inferences that can be made with regard to the 
contribution of individual treatment components are limited. This is at least in part 
due to the multiple intervention procedures that were implemented with each of the 
children in the treatment of their sleep difficulties. The various intervention 
procedures were introduced simultaneously for each child, rather than in a staggered 
fashion. This means that it is not possible to isolate the specific methods were 
responsible for the treatment effects seen, or determine whether the effects were a 
result of the synthesis of treatment procedures. This is a common limitation referred 
to in relevant literature, as a drawback of multi-component interventions (Knight & 
Johnson, 2014; Moore, 2004). Despite this limitation, the multi-component 
interventions carried out in the current study, and the FBA used to construct them, 
were successful in treating the participants’ sleep disturbance. As such, the findings 
of the current study still have significant clinical implications.  
 
A second limitation of the current study concerns the reliance on psychometrics 
to track any change to the children’s general behaviour and their parents’ wellbeing 
as a result of treatment. Psychometrics are susceptible to response bias on the part 
of the parents, responding on behalf of their children regarding their behaviour, and 
self-report measures of their own wellbeing, as the parents are not blind to the 
intervention (Weiskop et al., 2005). Further, psychometrics of these sorts only 
measure perceptions and do not provide objective data (Moore, 2004). A more 
accurate method of data collection for child-related variables could be to administer 
these measures to multiple appropriate respondents/sources, which would allow for 
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the triangulation of data and increase the validity of the results found. Greater 
precision of measurement could also be achieved by recording the frequency and 
duration of any behaviours of interest, such as externalizing behaviours. The 
psychometric measures used in the current study have elicited some useful 
preliminary insights within the scope of this investigation, which would in future 
benefit from further research utilizing more quantitative and objective measures. 
 
Thirdly, the current study is limited by the restricted generalizability of the 
results, due to a number of factors. Among these factors is the small sample size, 
which despite of its provision of robust internal validity of the findings through the 
enablement of extensive examination of the functional relationship between the 
intervention and the outcomes, restricts the external validity. The lack of 
representation of other RGND diagnoses across the current study’s participants also 
limits the generalizability of the results, given the distinctiveness of each RGND. 
Furthermore, the variability in the clinical features and behavioural presentation 
within each RGND hinders the applicability of the results to children with the same 
diagnoses as those included in this study. Most pertinently, it is not certain that the 
sleep disturbance exhibited by the children in the current study are representative of 
all children with RGND. 
 
Another limitation involves the lack of reliability data procured through the 
examination of video footage, without which inter-observer agreement cannot be 
established. Due to time constraints, the video footage collected from each of the 
families had not been coded by the time of submission and the triangulation of sleep 
measures was not possible. Therefore, parental report via sleep diaries was the sole 
means of obtaining primary sleep data. Because of this, reliability of their reporting 
was not confirmed, which may pose as a threat to the internal validity of any 
conclusions drawn from the results (Didden et al., 2002). Other studies that have 
encountered this methodological limitation (Weiskop et al., 2005). 
	 135	
 
The time restrictions surrounding the current study also limited the collection of 
short-term follow-up data for Hannah, and long-term follow-up data for all of the 
participants. Consequently, maintenance of the treatment effects observed was not 
confirmed at the time of submission. It is intended that long-term follow-up phases 
will be carried out 12-weeks post-intervention for the three participants.  
 
Future Directions 
 The findings and limitations of the current study provide ample justification and 
direction for future research.  
 
One possible research endeavor within this area could strive to assess the 
effect that sleep interventions have on general child behaviour and parental 
wellbeing, using more objective measures. The current study depended exclusively 
on psychometrics to obtain this information about the participants and their families, 
leading to the reduced internal validity of the overall study. A more comprehensive 
method of measurement could be executed wherein the frequency and duration of 
specified child behaviours of interest could be charted in a manner similar to that 
used with the primary sleep variables in the current study. Similarly, variables 
pertaining to family wellbeing could be measured more objectively by employing 
such methods. 
 
On the subject of the impact of sleep interventions on the child’s family, the 
findings of the current study point to another encouraging area of interest, that being 
the effect of treatment on the child’s siblings. Hannah’s mother reported that 
following the implementation of Hannah’s sleep intervention, her younger sister’s 
sleep also improved. This information was communicated anecdotally through the 
post-treatment interview, but future research could investigate this effect using more 
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quantitative measures in order to draw more valid conclusions about the relationship 
between sleep interventions and sibling’s sleep. 
 
Within the current study, the sample size was small and included only a couple 
of different RGND diagnoses. Due to this, the findings may not be generalizable to 
the wider RGND population, which contains numerous genetic profiles and 
phenotypic presentations which may not respond to the interventions employed in 
this study in a manner alike with the current participants. Therefore, future research 
should strive to include larger samples, with a greater representation of different 
ages and RGND diagnoses, so that FBA-based behavioural sleep interventions may 
become more confidently prescribed within this cohort.  
 
Given that the treatment carried out in this study involved multiple intervention 
procedures that were implemented at once, it is not possible to determine which 
individual procedures had the most potent effect. However, there were techniques 
carried out across all of the participants that were highly acclaimed by the parents, 
and may therefore be worth consideration for use in clinical practice. The social 
stories, Groclocks, and sleep-wake scheduling were applauded by the parents in 
their post-treatment interviews as having made a visible difference to their child’s 
sleep-related behaviours. While this is only anecdotal evidence, these reports along 
with the success of the overall intervention package should warrant consideration for 
utilization in future research. In addition, the extinction-based procedures that saw 
the removal of parental presence at sleep onset and during night wakings were also 
implemented across the three participants. Although not highlighted in the post-
treatment interviews, the amplified behavioural responses or PERBs exhibited by 
Michael following the removal of parental presence could signal its appropriateness 
as a treatment technique in this case. The increase in curtain calls, sleep onset 
latency, and night wakings that occurred for Michael resembles a post extinction 
response burst, which commonly occurs following the implementation of such 
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procedures, when parental presence is in fact the reinforcement maintaining their 
behaviour. The extinction bursts were not long-lasting, and sleep variables did 
improve over the course of intervention, which lends support for its effectiveness and 
advocates for further exploration in future research with children with RGND. 
 
Conclusion 
The objective of the current study was to gauge the effectiveness of FBA-based 
behavioural interventions in the treatment of sleep disturbance amongst children with 
RGND, as well as to ascertain whether there were any secondary effects of 
treatment related to general child behaviour and parental wellbeing, sleep, and 
relationship satisfaction, and finally to determine the level of treatment acceptability 
held amongst the parents of the participants. In conclusion, the study found variable 
levels of improvement, ranging from no change to complete elimination of sleep 
disturbance, across the measured sleep variables for all three children, as well as 
maintenance of treatment effects in cases. Considerable variation was similarly 
observed in the results of general child behaviour measures and measures of 
parental wellbeing, sleep, and relationship quality. Following intervention, parents 
rated their acceptance of treatment highly, and provided praise for the intervention 
and study process overall in their post-treatment interviews. The overall success of 
the interventions developed for and carried out with the children in this study 
provides substantiation for the use of FBA, specifically with children with RGND, 
however the variability in the results for secondary outcome measures calls for 
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